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ABSTRACT 
 
   The objective of this study was to investigate the compliance phenomenon and patient-
perceived problems mainly from the viewpoint of hypertension. This study involved two cross-
sectional study populations. The first one consisted of 482 pharmacy-based hypertensive 
patients from Oulu and Tampere in Finland. These patients participated in the study between 
May and August 1996. The second study population of 1561 medically treated and 220 
medically untreated patients were drawn from the Finnish national study of hypertensive 
patients in primary health care in 1996. The patients were identified during one week in 
November followed up with a health examination.  
   Logistic regression analyses were used to study the associations between variables in both 
study populations. In addition, factor, reliability and internal validity analyses were used to 
identify patient-perceived problems in the second study population. 
   It turned out that almost all medically treated hypertensive patients (98%) had patient-
perceived problems and each patient had an average of five problems. The most common 
problem was the perceived lack of follow-up by the health centre (72%). Two-thirds of patients 
had difficulties to accept being hypertensive patient and showed a careless attitude towards their 
hypertension. Over half of the patients reported a lack of information concerning hypertension. 
High levels of patient-perceived problems in the categories of everyday life related problems, 
health care system related problems and patient-related problems were associated with multiple 
risks of intentional non-compliance with antihypertensive medication. Furthermore, patient-
perceived everyday life related problems, a hopeless attitude towards hypertension and 
frustration with treatment were associated with poor outcomes of antihypertensive drug therapy. 
   A theoretical classificatory model of non-compliance and non-concordance, which divided 
this phenomenon first as intentional and non-intentional, was also created. The intentional forms 
are: “individualistic way of taking care of one’s health”, “intelligent choice”, “ethical/moral or 
religious values” and “priorities of life”. When the viewpoint is concordance, only “priorities of 
life” remain in the model. The non-intentional forms are: “forgetfulness”, “lack of attention”, 
“disease”, “misunderstandings or lack of information” and “problems in the supply or use of 
medicines”.   
   In conclusion, the findings of this study showed that the treatment of hypertensive patients in 
Finland is far from optimal from the patients’ perspective. When these findings are combined 
with the age structure of the Finnish population, hypertension continues to be a public health 
problem. There is a risk of non-compliance with practically every medical and non-medical 
treatment, and profound understanding of the phenomenon is essential for achieving better 
treatment outcomes in medical practice.  
 
National Library of Medicine Classification: W 85, WG 340 
Medical Subject Headings: patient compliance; hypertension/drug therapy; treatment outcome; 
health behavior; patient acceptance of health care; attitude; religion; morals; life style; primary 
health care; pharmacies; cross-sectional studies 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Let no man deceive himself. 
 If any man among you seemeth 
 to be wise in this world, 
 let him become a fool, 
 that he may be wise 
 (I CORINTHIANS 3:18 KJV). 
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1 INTRODUCTION  
 
   Non-compliance, i.e. how well patients follow given instructions, is a complex 
phenomenon, which concerns practically every medical and non-medical treatment. 
These problems are present even in possibly life-threatening conditions (Wright 1993). 
Several theoretical models have been proposed to explain non-compliant behaviour, but 
with quite poor success. One reason may be that these theories have been applied to all 
non-compliant patients without differentiating between intentional and non-intentional 
behaviour (Barber 2002). Despite active research, our knowledge of the phenomenon of 
non-compliance continues to be insufficient. There is an obvious need to reach more 
profound understanding of compliance and non-compliance. 
   In this study, compliance will be approached from the perspective of hypertension, 
which is the most common chronic disease among the Finnish population. Half a 
million Finns have been registered as entitled to special reimbursement from Social 
Insurance Institution for their antihypertensive medication (Klaukka 2005). In addition, 
there is a large number of persons who also use antihypertensive medication, but have 
not yet received this certification. Another large group is those patients who know that 
their blood pressure is raised, but who have no medication at all.    
   Recent findings from the Framingham study showed that half of normotensive 55- 
year-olds and over two-thirds of normotensive 65-year-olds will develop hypertension 
within the next ten years (Vasan et al. 2002). In the next few years, a very large number 
of Finns will reach the high-risk age (Suomen lääketilasto 2002). This will pose a 
challenge to the Finnish health care system, because hypertension is an expensive 
disease due to its cardiovascular complications and medical treatments. In addition, the 
human suffering caused by hypertension to the patients and their close relatives is 
immeasurable.  
   It has been recently shown that only every fourth Finnish hypertensive patient in 
primary care has reached the goal of blood pressures values under 140/85 mmHg 
(Meriranta et al. 2004). These poor outcomes of hypertension treatment are alarming, 
but they do not give us any idea about the patients’ perspectives of hypertension 
treatment. Traditionally, medical treatment has held the key role in hypertension 
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treatment regardless of patients’ concerns and wishes. However, this approach involves 
the risk of losing the patient perspective. As long as the focus of treatment is something 
other than the patient, the patient perspective tends to get lost. The treatment of 
hypertension with adverse drug effects and symptoms may be very troublesome for the 
patient. Such aspects as patients’ attitudes and perceived problems related to different 
aspects of hypertension treatment have so far received little attention in research. To 
better understand the poor outcomes of treatment, we also need information from the 
patients’ perspective.  
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2 REVIEW OF THE LITERATURE 
 
2.1 Defining and measuring compliance 
2.1.1 Definitions of compliance 
 
   Before the year 1974, most of the world’s knowledge of compliance in modern 
medicine could be found in 245 scientific articles, and these included a few articles 
dating back to the 1940’s (Haynes 1979). In 1976, David Sackett and Brian Haynes 
published one of the first books on compliance, which was followed by a more 
comprehensive book (Brian Haynes, Wayne Taylor and David Sackett) in 1979 titled 
“Compliance in Health Care”, which summarized the state of the art in compliance 
research. In this book, compliance was defined as “the extent to which a person’s 
behavior (in terms of taking medications, following diets, or executing lifestyle 
changes) coincides with medical or health advice”. This definition has held its status up 
to the present time. According to Haynes (1979), the terms ‘compliance’ and 
‘adherence’ can be used interchangeably, while Lutfey and Wishner (1999), for 
instance, thought that the term ‘adherence’ includes more of the patient’s right to self-
determination concerning his/her treatment than the term ‘compliance’.  
   In his introduction to “Compliance in Health Care” Brian Haynes (1979) comments 
that, although some steps forward have been taken, however, the solution of non-
compliance is still not in sight. Since then, the associations of compliance with over 200 
background variables have been studied (Morisky et al 1986). In the 1990’s, the 
MEDLINE database included 2630 articles focusing on compliance, and despite the 
numerous compliance studies in the 1980’s and 1990’s, only a few new insights were 
introduced (Farmer 1999, Vermeire et al 2001). The last 30 years of research on 
compliance have not produced much more reliable information than that patients do not 
always take their medications as prescribed (Morris and Schulz 1992). Furthermore, the 
studied variables have been mainly contradictory in different studies and are thus not 
useful in explaining compliance (Morris and Schulz 1992). A quarter of a century after 
the publication of first book, Brian Haynes and his colleagues (2002) comment that 
there is a need for studies that are able to improve compliance. Furthermore, the studies 
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that have successfully used long-term medications have been complex, and at best, have 
had only modest effects on non-compliance.  
   In the literature, when defining compliance there seems to be a common thought that 
the patient’s behaviour is the exclusive reason for non-compliance, without taking into 
account the roles of the physician, the health care organization and the patient-doctor 
relationship, which might show non-compliance to be due to concordance problems 
between the patient and health care professionals (Lutfey and Wishner 1999, Nilsson 
2002). The problem with the term ‘compliance’ has been the perception that the patient 
receives commands from healthcare professionals. Therefore, the term ‘concordance’ 
was recently introduced, which looks at compliance from a different perspective. 
”Concordance is a new approach to the prescribing and taking of medicines (Dickinson 
et al. 1999). It is an agreement reached after negotiation between a patient and a 
healthcare professional that respects the beliefs and wishes of the patient in determining 
whether, when, and how medicines are to be taken” (Dickinson et al. 1999). The 
patient’s views should be taken into account even if s/he does not actively participate in 
the decision-making process (Elwyn et al 2003). The making of maximally well-
informed treatment decisions is one of the keys to concordance (Dickinson et al. 1999). 
Thus, one important role of the physician is to ensure that the patient has adequate 
access to information and, when necessary provide an interpretation of this information 
to the patient (Kennedy 2003). Furthermore, if the patient lets you know that s/he does 
not want to take a certain medicine, the reasons for that should be discussed (Elwyn et 
al 2003). It is not meaningful to discuss compliance when a patient has been offered 
treatment that s/he finds unacceptable because of ethical/moral or religious reasons, 
while concordance does not present a problem in a corresponding situation. The patient 
hence has the right to choose whether or not s/he accepts the medication, and the health 
care professional should accept this as a part of the process of moving from compliance 
to concordance (Heath 2003).   
   However, there might be some situations where the use of ‘concordance’ and the 
patient as a decision-maker are problematic. These are clinical trials where almost full 
compliance is needed to ensure reliable results (Milburn and Cochrane 1997). The 
research on human medication-taking behaviour is also related to compliance and thus 
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not suitable for the ‘concordance’ concept (Milburn and Cochrane 1997). Furthermore, 
‘concordance’ is not useful in the case of potentially fatal infectious diseases because 
persons with this kind of disease will risk the health of other people by infecting them 
and contributing to bacterial resistance against antibiotics (Milburn and Cochrane 
1997). ‘Concordance’ usually involves two persons, but what if there are more persons 
involved than just the patient and the physician, e.g. the parents of a child, it is obvious 
that the situation is then more complex (Sanz 2003).  
   It has also been suggested that the decision to involve the patient into decision-making 
should be made individually in each case by taking into account their comprehension 
and decision-making abilities (Lakshmi 1999, Lamont 1999). Patients come to seek help 
from a physician, and if the decision-making is repeatedly left to the patient s/he may 
ultimately lose respect for the physician (Carvel 1999). However, the patient as a co-
worker is essential for effective discussion between the patient and the physician, where 
mutual understanding will lead to a rapid diagnosis, and discussion of treatment choices 
may lead to a higher probability of good compliance (Slowie 1999). 
   As a conclusion, what is needed for successful concordance? Patients need clear, 
unambiguous information about things that matter to them, and physicians need 
practical tools for sharing that information (Jones 2003). Furthermore, the biggest future 
challenge for the concept of concordance will be the need of health care professionals to 
adopt new values (Jones 2003). 
 
 
2.1.2 Compliance as a phenomenon 
 
   Studies have shown that non-compliance is associated with poor treatment outcomes 
in hypertension treatment (Mallion et al 1998). Furthermore, it was found among 
treatment-resistant hypertensive patients with a three-drug combination that one-third of 
the patients’ blood pressure values were normalized by using compliance monitoring 
alone (Burnier et al 2001). However, a recent review of compliance with 
antihypertensive medication, which included studies where electronic devices had been 
used to measure compliance, concluded that there is no convincing evidence to support 
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the association between non-compliance and blood pressure control (Wetzels et al 
2004). This result can be understood in two ways. Either our antihypertensive drugs are 
ineffective or our methods of measuring compliance are inadequate.   
   Non-compliance is a universal problem, and it also concerns possible life-threatening 
conditions (Wright 1993). Intentional non-compliance is common even among HIV 
patients who have experienced adverse drug effects (Heath et al 2002). A recent study 
of renal transplant patients indicated that late acute rejections were more prevalent 
among non-compliant patients with immunosuppressive therapy (Vlaminck et al 2004). 
Non-compliance in organ transplant recipients usually also ranged between 20% and 
50% and was associated with graft loss and death (Laederach-Hofmann and Bunzel 
2000). Not even patient education is enough to ensure good compliance of patients with 
organ transplants. In these cases the important issue is that the graft that has been lost 
because of non-compliance could have been transplanted into somebody else, who 
might have lived with a trasnsplant but died while waiting for the graft (Laederach-
Hofmann and Bunzel 2000).  
   Studies have also shown that good compliance with placebo has been associated with 
better treatment outcomes than non-compliance with the use of placebo tablets (Horwitz 
and Horwitz 1993). This goes to demonstrate that compliance is a complex 
phenomenon. Unwillingness to take medicines is a profound and widespread problem 
(Vermeire et al 2001). It has been suggested, possibly with humour, that research on 
patients’ medication-taking could be called reality-based medicine to distinguish it from 
evidence-based medicine (Chapman 2000). 
   The crucial questions in the efforts to control chronic diseases are: Do patients follow 
the instructions and take their drugs, and how well are the physicians aware of this 
(Chapman 2000)? For the physician, it is naturally much easier to write out a 
prescription than spend annoying moments discussing the patient’s attitudes towards 
medication-taking (Chapman 2000). However, it is the health care personnel’s 
responsibility to understand the help-seeking patient’s view (Delgado 2000). Maybe we 
should not pay attention to compliance, but rather to our ability to understand and 
participate in patients’ decision-making processes about their medication-taking 
(Donovan and Blake 1992). Patients today make their decisions about medication-
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taking on their own, but simple information sharing would allow them to make 
decisions that better fit their life situation and beliefs and would also offer the view of 
modern medicine about the benefits and harmful effects of drugs (Donovan and Blake 
1992). The advice given by the physician needs to compete with many other opinions 
before the patient decides about whether or not s/he will follow the physician’s advice 
about treatment (Donovan and Blake 1992). It is up to the physician to make sure that 
the patient tells about all of his/her medication problems and to offer enough 
information to make the patient convinced of the suitability of his/her medication 
(DiMatteo 1994).  Even when the patient accepts the treatment prescribed to him/her, 
success dependent on how difficult it is to follow the treatment instructions and whether 
s/he receives support in the treatment process (DiMatteo 1994).   
 
 
2.1.3 Classification and measurement of compliance 
 
Compliance as a variable 
   It has been suggested that the distribution of compliance with antihypertensive 
medication would be roughly U-shaped, i.e. one-third of patients would take practically 
no drugs at all, one-third would take nearly all drugs, and one-third would fall between 
these extremes (Sackett and Snow 1979). Compliance with long-term medications in 
different diseases seems to be about 50% (Sackett and Snow 1979). However, there are 
problems in reporting the compliance percentage. Compliance of 50% may mean that 
half of the patients stopped taking their medication, or that patients consume an average 
of 50% of the medications prescribed to them (Farmer 1999). A patient who takes an 
average 50% of the medications prescribed to him/her may take half of the medications 
every day or all the medications every second day or engage in various combinations of 
taking and not taking medications. Apart from this, non-compliance may manifest at 
many different stages of medication-taking behaviour. In long-term treatment, 
compliance may change when the life situation changes and otherwise over time 
(Kyngäs et al 2000). Furthermore, patients may be compliant with certain instructions 
but not with others (Kyngäs et al 2000).  
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Classification of compliance 
   It has been found that at least 80 percent of prescribed antihypertensive medications 
should be taken to achieve a systematic response to therapy (Sackett and Snow 1979). 
Therefore, in hypertension research, 80 percent has often been used as the limit for 
acceptable compliance. However, all cases of non-compliance should be checked 
whether one dosage or more and abandoning the 80% limit would offer benefits (Barber 
2002). 
   In organ transplant recipients, compliance has been differentiated into clinical non-
compliance and subclinical non-compliance (Laederach-Hofmann and Bunzel 2000). 
Clinical non-compliance refers to clinically measurable events, such as rejection 
episodes, graft losses and death. Subclinical non-compliance is shown by patients who 
have been identified to be non-compliant, but who have not yet had clinically observed 
adverse effects (Laederach-Hofmann and Bunzel 2000). 
   White-coat compliance has been used to describe the phenomenon, of an approaching 
office visit improving compliance, because it functions as a reminder or a threat 
(Feinstein 1990). This temporary improvement of compliance has been compared to 
dental visits, before which people brush their teeth with higher probability (Feinstein 
1990). 
   Compliance has also been differentiated into full compliance, partial compliance and 
total non-compliance (Feinstein 1990). Partial compliance is shown by patients who 
take enough medicines to be considered to accept the principles of treatment, but often 
they do not take or take the dosages so late, that they do not reach the full benefits of 
treatment (Feinstein 1990). 
   The term intelligent non-compliance has been applied to situations, where deviation 
from the physician’s instructions improves the patient’s health.     
   Drug holidays refer to situations where the patient repeatedly and suddenly 
discontinues his/her medication for at least one day and then suddenly resumes it again 
(Laederach-Hofmann and Bunzel 2000). 
   Compliance has also been classified as intentional and non-intentional compliance. A 
patient showing intentional non-compliance knows how s/he should function, but has 
made a conscious decision about the way s/he behaves and thus deviates intentionally 
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from the physician’s advice, while a patient showing non-intentional non-compliance 
would like to function according to the physician’s advice, but is for some reason 
unable to do that (Cochrane et al. 1999, Barber 2002).  
 
Measurement of compliance 
   The ideal method for measuring compliance should have the following characteristics: 
it should avoid dividing the phenomenon into two separate groups, it should be 
relatively cheap, it should give reliable and objective estimates, it should give 
continuous information about the history of compliance, it should avoid affecting the 
patient’s behaviour, and it should be easy to use and analyze (Farmer 1999). However, 
no-one has been able to develop a method of this kind. Today, there are many methods 
for the measurement of compliance, but none of them can be regarded as the method of 
choice. Each method has its own strengths and weaknesses, and it is therefore 
recommendable to use several methods simultaneously (Farmer 1999). The methods for 
measuring compliance can be divided into direct and indirect methods. Direct methods 
give evidence that the patient has been taking the drug, but may give false results if the 
patient takes the drug immediately before testing (Morris and Schulz 1992, Farmer 
1999). Indirect methods of compliance measurement are used more often, but they do 
not give direct evidence of drug intake (Morris and Schulz 1992). The use of different 
measuring methods makes the comparison of compliance studies difficult, and the use 
of different definitions of compliance make comparisons practically impossible (Morris 
and Schulz 1992).  
 
Direct methods  
   Direct methods of measuring compliance include direct observation of the patient’s 
medication-taking or determinations of the concentration of the drug, the drug’s 
metabolite or some biological marker from blood, urine or saliva. When using drugs, 
metabolites and biological markers, one problem is due to the individual differences in 
kinetics. For instance, the serum concentrations of a substance may be similar, although 
drugs have been used very differently (Farmer 1999). Another problem in chronic 
medication is the question of how representative of long-term behaviour one random 
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sample can be. The daily patterns of drug intake often also remain obscure. An ideal 
biological marker should be safe, tasteless, colourless, odourless, pharmacologically 
inert in human, chemically unreacting, cheap, small in volume and detectable from 
urine with a simple, sensitive and specific method (Ellard et al 1980). The observation 
of a patient’s medication-taking may also involve problems, because the patient can 
pretend taking the drug, and the method is impractical in an outpatient setting (Farmer 
1999).  
 
Indirect methods  
   Indirect methods of compliance measurement include physicians’ estimates, patients’ 
self-reports (interview, diary, questionnaire), tablet counts, medication-taking files and 
electronic medication devices. The physician’s estimation of a patient’s compliance has 
been used to some extent, but is less used today because of its unreliability. In a large 
Japanese study, data were collected independently from hypertensive patients and 
physicians, who treated hypertensive patients (Toyoshima et al 1997). The physicians 
estimated 16% of their patients to be non-compliant, while the percentage according to 
the patients’ report was 35%. Similarly, in a German study, 57% of hypertensive 
patients were moderately compliant according to physicians’ estimates and 1% were 
non-compliant (Dusing et al 1998). However, 55% of the patients admitted being 
occasionally non-compliant, and 13% reported being often non-compliant. 
   The measurement of compliance is easiest based on patients’ own reporting, but the 
method is unreliable for those who report being compliant (Farmer 1999). It has been 
found that self-reported compliance (telephone survey) and filled prescriptions are in 
very poor agreement, and that overstating compliance is associated with fewer visits to 
health care providers (Wang et al 2004). Interviews have been found to be less reliable 
than questionnaires or diaries compared to non-self-report measures (Garber et al 2004). 
Table 1 shows an example of Morisky’s et al (1986) set of four compliance questions, 
which are based on the theory that the mistakes and neglects in taking medication could 
be due to forgetfulness, carelessness and the tendency to stopping taking medication 
when feeling better and resuming medication when feeling worse. Furthermore, the 
questions were intentionally formulated so that the positive reply alternative ”yes” 
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indicated poor compliance. The reliability of the results can be further influenced by the 
skills of the interviewer, the structure of the questions and a blaming tone (Farmer 
1999).   
   Tablet counts, which were extensively used in the 1970’s and 1980’s, are problematic 
because patients can modify the number of remaining tablets before the count. 
Furthermore, when the tablet count is done in the clinic, it is difficult to get the patient 
to bring all the medications with him/her (Haynes et al 1980). It is also impossible to get 
information about the days on which the patient took too many, too few or the correct 
number of tablets.  
   With long-term medication, it is possible to estimate compliance based on refill data 
from prescription or reimbursement files. One advantage of using prescription 
information is that it can be done unobtrusively (Enlund 1982). It is also usable in the 
routine clinical care of patients. A good example of how to combine pharmacy records 
with another method (in this case telephone interview) is the study of Sharkness and 
Snow (1992), which showed two-thirds of patients to be non-compliant (Table 1). 
   The development of different electronic medication devices changed compliance 
research in the 1990’s. These devices record such information as the time and date when 
the patient opens the drug container and thereby give continuous information of 
medication-taking (Farmer 1999). There is, however, the problem that although the 
device has been used, there is no way of knowing whether or not the patient has actually 
taken the dose of medication. The measurement of compliance by asking the patient or 
by tablet count is likely to lead to overestimation of compliance compared to electronic 
medication devices (Mallion and Schmitt 2001). Choo et al (1999) studied 286 
hypertensive patients on monotherapy and found that the proportion of tablets taken was 
higher than the proportion of tablets taken at the correct time. Furthermore, the 
compliance reported by patients compared to electronic medication devices led to 
misclassification of good compliance, while reported non-compliance was usually 
classified correctly. The same phenomenon was also recorded in an American study 
where non-compliance with intentional emptying of the inhalator was studied during a 
clinical trial of COPD treatment (Simmons et al 2000). Thirty percent of 101 study 
persons who thought that the inhalator only measures the number of doses taken, used 
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the inhalator over a hundred times within three hours at least once during the first year 
of the study. Only one of the 135 other study persons, who were fully aware of the 
details of inhalator observation did so. A majority of these instances of inhalator use 
took place shortly before a follow-up visit, suggesting attempts to hide non-compliant 
behaviour. The compliance rates based on patients’ reports and the weight of the 
inhalator were similar in these groups, while based on the information from the 
inhalator compliance was poorer in the group who intentionally emptied the inhalator 
than in the other group. 
 Table 1. Compliance with antihypertensive medication using different methods of measument in the 1990’s and 2000’s. 
 
Reference Number of 
hypertensive 
patients  
Method for measuring compliance Aspect of non-  
compliance mainly 
measured 
Comp-
liance 
(%) 
Patel and 
Taylor 2002
102 Questions in the method of Morisky and colleagues (1986): 1. ”Did you 
ever forget to take your (blood pressure) medicine? 2. Are you careless at 
times about taking your (blood pressure) medicine? 3. When you feel better, 
do you sometimes stop taking your (blood pressure) medicine? 4. 
Sometimes, if you feel worse when you take your (blood pressure) 
medicine, do you stop taking it?” Patients who answered ”no” to all of the 
four questions were classified as compliant. 
1. Memory problems, 
etc.  
2. Secondary memory 
problems  
3. Intentional 
4. Intentional  
 
68 
Choo et al. 
2001 
286    1. Questionnaire. ”While you were using the special medication bottle, on 
how many days in an AVERAGE WEEK did you forget to take a pill?” 
Good compliance = dosage has been missed less than once a week. 
   2. Electronic pill box. Good compliance = dosage has been missed less 
than once a week. 
   3. Combination of the previous two questions. 
1. Memory problems,  
etc. 
 
2. All aspects 
 
3. All aspects 
79 
 
 
58 
 
51 
Svensson et 
al. 2000 
33 Interview. The following questions to clarify compliance were asked: ”Have 
you thought about changing your medication yourself?”, “Have you 
considered not taking the tablets?” The answers were specified with 
additional questions and also analyzed according to the replies to the other 
questions. Good compliance = never or rarely changed or omitted 
medication without consulting a physician. 
Both questions asked 
intentional at attitude 
level. Finally 
intentional. 
 
58 
Kyngäs and 
Lahdenperä 
1999 
65% of 138 
patients were 
medically 
treated 
Only these questions were specified in the article: 1. Patients that reported 
changing their medication according symptoms by themselves. 
2. Patients that “often forgot to take medication or did not take it regularly.” 
3. All four questions used in the study. 
1. Intentional 
 
2. Several aspects 
3. Several aspects 
95 
 
90 
75 
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 Table 1. continues. 
     
Reference Number of 
hypertensive 
patients  
Method for measuring compliance Aspect of non-  
compliance mainly 
measured 
Comp-
liance 
(%) 
Toyoshima 
et al. 1997 
6289    1. Questionnaire to physicians. Physicians’ (n =  4417) estimation about 
their hypertensive patients. 
   2. Questionnaire to patients. Four questions about intentional non-
compliance related to extension of the medication-taking intervals, 
reduction of dosage, stopping and resuming of medication and complete 
discontinuation of medication.  
   3. Questionnaire to patients. Non-intentional non-compliance was clarified 
with a question related to the frequency of forgetting to take medicine.  
   4. Combination of the previous two questions.  
 
1. Intentional and 
memory problems, etc. 
2. Intentional 
 
 
 
3. Memory problems, 
etc.  
4. Intentional and 
memory problems, etc. 
 
84 
 
80 
 
 
 
74 
 
65 
 
 
Mallion et 
al. 1996 
501 Electronic pill box.  
   1. Good compliance 80-100% and non-compliance <80% or >100%.  
   2. Good compliance = every dose was taken.  
 
 
1. All aspects 
2. All aspects 
 
63 
about 35 
Shaw et al. 
1995 
98 Questionnaire based on telephone interview. 
   1. ”Many people find it difficult to remember to take their medicine. How 
often do you miss a dose of? (name of antihypertensive drug)”  
   2. ”Have you ever missed any doses on purpose?”     
   3. Combination of the previous two questions. 
 
1. Memory problems, 
etc.  
2. Intentional 
3. Combination of the 
previous two 
questions. 
 
70 
 
67 
54 
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Table 1. continues. 
     
Reference Number of 
hypertensive 
patients  
Method for measuring compliance Aspect of non-  
compliance mainly 
measured 
Comp-
liance 
(%) 
Wallenius 
et al. 1995 
623 In the questionnaire it was asked whether the patients sometimes or often 
tried to manage with a lower dose and/or fewer drugs than prescribed. 
Intentional 64 
Richardson 
et al. 1993 
197    1. Questionnaire. Question about missing medication over the past week 
and in general.  
   2. Nurse interview. Number of pills missed on an average week.  
    
   3. Combination of the previous two questions. 
 
1. Memory problems, 
etc.  
2. Memory problems, 
etc.  
3. Memory problems, 
etc.  
65 
 
61 
 
53 
Sharkness 
and Snow 
1992 
125    1. Pharmacy records. Compliance was considered adequate if the patient 
had collected  80% of antihypertensive medicines prescribed  to him/her. 
   2. Structured telephone interview. Compliance was based on the number 
of pills missed or the number of extra pills taken per week on an average. 
  
   3. Combination of the previous two questions. 
1. All aspects 
 
2. Memory problems, 
etc. and intentional 
overdosage 
3. All aspects 
56 
 
42 
 
 
32 
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2.2 Factors associated with non-compliance 
2.2.1 Non-compliance and hypertension 
  
   According to a literature review on randomized controlled trials to improve 
compliance, 7 of 15 interventions were associated with improvement of compliance and 
6 with improvement of treatment outcome (Haynes et al 1996). Effective interventions 
in long-term care were complex and included different combinations of more 
convenient care, information, counselling, reminders for appointments and missed drug 
refills, self-monitoring of medication-taking and blood pressure, support to compliance, 
family therapy and other forms of extra supervision or attention. Even the most effective 
interventions did not lead to a substantial improvement of compliance. There are only a 
handful of rigorous compliance intervention studies among the thousands of studies on 
compliance (Haynes et al 1996). Since compliance is a problem in all treatment 
regimens in which medications are to be taken by patients, an improvement in basic and 
applied compliance research would be profitable. The application of new knowledge of 
how to effectively improve compliance would have a much greater effect on health than 
any existing treatment (Haynes et al 1996).  
   In a more recent systematic review of randomized controlled trials aiming to increase 
compliance with antihypertensive medication, it was found that reduction of the number 
of daily doses seems to be the most promising method (Schroeder et al 2004). The 
connection of this with blood pressure was not so promising. However, skipping a 
single dose means an approximately 48-hour interval between doses in a once a day 
regimen, while the corresponding interval is approximately 24 hours in a twice a day 
regimen (Waeber 2004). The study also showed that patient education alone was not a 
successful method (Schroeder et al 2004). However, some motivational and complex 
methods are promising, but because of insufficient evidence, they cannot be 
recommended based on our current knowledge level. Furthermore, the writers comment 
that even the best methods for improving compliance and treatment outcomes have not 
been very effective.  
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   Another problem today is that the use of many different measurement methods make 
the comparison of compliance studies difficult and the use of different compliance 
definitions makes these comparisons virtually impossible (Morris and Schulz 1992).  
   The following sections present different factors associated with compliance, and these 
factors are shown summarized in Table 2. 
 
Table 2. Factors associated with good compliance. 
 
Hypertension and its 
treatment 
Health care system and 
personnel 
Patient 
- certain groups of 
 antihypertensive drugs 
- dosage once a day  
- morning dosage 
- shorter duration of 
 medication 
- no adverse drug effects 
- symptoms of disease 
- previous hospitalizations 
   because of cardiovascular 
 disease 
- reasonable costs 
- effectiveness of treatment 
- the way the benefits of 
 treatment are presented 
- trust in physicians 
- understanding the benefits  
 of treatment 
- no memory problems 
- no incorrect disease- 
 related beliefs 
- certain cultural and 
 attitudinal factors or their 
 absence 
- older age 
- device for measuring 
 blood pressure at home 
- regular living habits 
 
 
The type of antihypertensive drug 
   A study in the United States on nearly 22.000 patients followed up the continuation of 
the first antihypertensive medication (no antihypertensive medications in previous 12 
months) during 12 months (Bloom 1998). It turned out that the use of angiotensin II 
antagonist (losartan) was associated with better continuation of medication compared to 
ACE inhibitors, calcium channel blockers, beta-blocking agents and thiazide diuretics. 
However, caution is needed in interpreting this result, because the size of the 
angiotensin II antagonist group was about one tenth of the size of all the other groups. 
Another study from the United States followed originally 7211 patients on monotherapy 
for hypertension during 12 months based on the Medicaid database (Rizzo and Simons 
1997). Patients on ACE inhibitors and calcium channel blockers showed better 
compliance (both 35%) than patients on beta-blocking agents (29%) and diuretics 
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(15%). Furthermore, in the UK study with over 10 000 hypertensive patients with new 
courses of antihypertensive drugs, it was found that, by month six, 51 to 59% of patients 
in all of the four major classes of antihypertensive drugs had changed or discontinued 
their new treatment (Jones et al. 1995) 
 
Number of daily doses  
   The association between the number of daily doses and compliance was studied in a 
meta-analysis of eight studies and 11.500 hypertensive patients (Iskedjian et al 2002). 
One dose a day was associated with better compliance than doses taken twice a day or 
more often. 
 
Timing of dosages  
   It seems that there are differences in compliance depending on the timing of dosage. A 
Japanese study of hypertensive patients showed compliance to be best with a morning 
dose, second best with an evening dose and worst with a daytime dose (Fujii and Seki 
1985). Furthermore, a French 4-week study followed hypertensive patients who had 
been advised to take their medications between seven and nine o’clock in the morning 
(Mallion et al 1996). By measuring compliance with an electronic pill box, it was found 
that there were more delayed doses at week-ends. 
 
Number of antihypertensive medications 
   A study in the United States on 98 hypertensive patients did not find an association 
between compliance and the number of antihypertensive medications (Shaw et al. 
1995). A Finnish study on 623 patients with antihypertensive medication similarly did 
not find an association between compliance and the number of cardiovascular 
medications (Wallenius et al. 1995). However, a Canadian study on 367 cardiovascular 
patients did find an association between non-compliance and fewer medications 
(Shalansky and Levy 2002). 
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Duration of hypertension 
   Wallenius et al (1995) found non-compliance to be associated with longer duration of 
antihypertensive medication. These findings are also supported by a large study from 
the United States concerning 7211 hypertensive patients (Rizzo and Simons 1997). 
However, another US study did not reveal a similar association (Patel and Taylor 2002). 
 
Experience of adverse drug effects and symptoms in patients with high blood 
pressure  
   Several studies have reported that perceived adverse drug effects are common. A 
Finnish study in 30 health centres with 3520 medically treated hypertensive patients 
showed that 10% of patients reported symptoms related to antihypertensive medication 
spontaneously and 20% did so when asked about symptoms by the physician 
(Kumpusalo et al 1997b). In a detailed symptom inquiry, 80% of patients reported at 
least one symptom and an average of four symptoms. A Norwegian study of 2586 
medically treated hypertensive patients also showed the prevalence of adverse drug 
effects to be dependant on the method of measurement (Olsen et al 1999). 16% of the 
patients reported adverse drug effects spontaneously, 24% when asked generally and 
62% when asked in detail. 
   Patients have reported antihypertensive drug-related adverse drug effects, including 
e.g. faintness and fatique, dizziness, cold feet or hands, headache, problems falling 
asleep or other sleeping problems, oedema, cough, muscular cramps, flushing, cardiac 
symptoms, dry mouth and psychological symptoms (Wallenius et al 1995, Kumpusalo 
et al 1997b, Ambrosioni et al 2000). 
   Wallenius et al (1995) found perceived adverse drug effects to be associated with 
intentional non-compliance. This was also found in a US study, which further indicated 
out that the patient’s knowledge about possible adverse drug effects was not associated 
with compliance (Shaw et al 1995). In several other studies patients have also reported 
adverse effects as the reason for their non-compliance (Cooper et al. 1982, Dusing et al. 
1998, Svensson et al. 2000). 
   In this respect the results of a randomized controlled trial where patients received an 
antihypertensive drug (n = 1105) or a placebo (n = 187) are noteworthy (Preston et al 
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2000). Unbearable adverse drug effects, which led to discontinuation of medication, 
were reported by 13% of the patients in the placebo group and 12% of the patients in the 
antihypertensive drug group. Sometimes it is difficult to distinguish the real adverse 
effects of antihypertensive treatment from the symptoms of hypertension (Flack et al. 
1996). Whether the adverse drug effects are real or not, health care professionals need to 
take the patient’s experiences seriously to ensure successful treatment of hypertension.  
   Hypertensive patients have also reported symptoms related to high blood pressure or 
rise of blood pressure including e.g. dizziness, headache, faintness, cardiac symptoms, 
flushing, nervousness, fatigue and tinnitus (Sharkness and Snow 1992, Wallenius et al 
1995). It is also good to think whether the patient’s symptoms could be due to 
something else, e.g. other diseases or their medication, living habits, nutrition or 
exercise. 
   In a US study on 125 medically treated men, 74% of the patients reported perceiving 
at least one symptom due to elevation of blood pressure (Sharkness and Snow 1992). 
58% of the patients rested or relaxed when they felt their blood pressure was rising, 
while the others started antihypertensive medication, took extra antihypertensive tablets, 
visited the physician or did not react to the situation. Furthermore, 79% felt that 
antihypertensive medication reduced symptoms. 
 
Other factors 
   Patients have also reported as reasons for their non-compliance feeling well without 
drugs or feeling worse than before medication and lack of symptoms of hypertension 
(Balazovjech and Hnilica 1993, Svensson et al. 2000). Furthermore, a lower prevalence 
of previous hospitalizations because of cardiovascular disease has been associated with 
discontinuation of antihypertensive medication (Degli Esposti et al 2002). 
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2.2.2 Non-compliance and the health care system 
 
Costs 
   The reasons for intentional non-compliance may be associated with costs (Delgado 
2000). Some patients have also reported attributed their non-compliance to the claim 
that they cannot afford to buy medicine (Cooper et al. 1982). However, medication is 
not the only source of costs. The office visit to a physician or a nurse may produce 
costs, as will transportation to different health care facilities.   
 
Medical visits 
   A study of 190 physicians and 3674 patients in six European countries showed that 
the average duration of a patient’s visit to the physician was 10.7 minutes (ranging from 
7.6 to 15.6 minutes) (Deveugele et al 2002). This is the time in which the physician 
should discuss treatment choices and convince the patient about the importance of 
following the instructions of the chosen treatment in addition to his/her other tasks.  
   A study carried out in the United States approached the association between the 
frequency of medical visits and compliance. It was found in a group low-income 
hypertensive patients who belonged to the Medicaid program that less frequent medical 
visits were associated with non-compliance according to the pharmacy records (Bailey 
et al 1996). The results of another US study suggested that frequent contacts with a 
physician may improve the continuation of therapy (Bull et al 2002). A third study from 
the United States, however, did not find an association between compliance and the 
time elapsed since the previous medical visit in a group of hypertensive patients (Shaw 
et al 1995). 
 
Satisfaction with treatment and health care professionals  
   A study from the United States with 197 patients on antihypertensive medication did 
not show satisfaction with health care professionals to be associated with compliance 
(Richardson et al 1993). Similarly, another study from the United States with 496 
hypertensive patients did not find an association between compliance and satisfaction 
with treatment (Wang et al 2002). 
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Knowledge of the physician  
   One essential factor for success in treatment is naturally the knowledge level of the 
health care professionals. In Germany, over 11 000 physicians filled in a questionnaire 
concerning their knowledge about the guidelines of German Hypertension Society 
(Hagemeister et al 2001). 19% of GPs, 26% of internists and 37% of cardiologists 
appeared to have sufficient knowledge about these guidelines. Thus, the reasons for 
non-compliance may also be associated with ineffectiveness of treatment (Delgado 
2000). On the other hand, knowledge and recognition of the level of non-compliance is 
important for physicians (Takala 1995).  
 
Presenting the benefits 
   The way in which the benefits of treatment are presented to the patient also influences 
compliance. In a UK study involving 89 hypertensive patients and 187 non-hypertensive 
patients aged 35 to 64 years, the subjects were asked whether they would accept 
antihypertensive medication to themselves (Misselbrook and Armstrong 2001). Mild 
hypertension was masked as a stroke-predicting factor 2 (SPF2). Acceptance of 
medication was elicited with the following questions: ”Would you take the pills 
described above if they reduced your risk of having a stroke by 45%? (risk reduction 
model)”, ”What if you were unlikely to have a stroke, so that it worked out that in a year 
you would have only a 1 in 400 chance of having a stroke, but the pills could reduce this 
to a 1 in 700 chance? Would you take the pills? (absolute risk reduction model)”, ”If the 
physician had to treat 35 patients for 25 years in order to prevent one stroke, do you 
think it would be worth taking the treatment for yourself? (number needed to treat 
(NNT) model)”, ”If the tablets had a 3% chance of doing you good by preventing a 
stroke and a 97% chance of doing no good or not being needed in your case would you 
take them? (personal probability of benefit from treatment model)”. Hypertensive 
patients accepted antihypertensive medication with higher probability than non-
hypertensive patients when presented the risk reduction model but there was no 
differences between the other models. 92% of the study subjects would accept 
antihypertensive medication in the context of the risk reduction model, 75% in the 
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absolute risk reduction model, 68% in the NNT model and 44% in the personal 
probability of benefit from treatment model. 
 
Two-way communication 
   However, it is not enough to provide understandable information, but the patient also 
needs to be allowed to ask questions about the matters that s/he perceives as important. 
This is also essential for successful sharing of information tailored according to needs. 
Patients have proposed posters in the waiting room to show that they are allowed to ask 
questions (Slowie 1999). Furthermore, in addition to the quantitative and qualitative 
aspects of information sharing, the communication process may also involve other kinds 
of problems. This is illustrated by the comments of a hypertensive patient about the 
attitudes of health care professionals: ”Eye contact is important, not looking at the 
watch. When confronting you with your illness, looking at you, tone of voice… asking 
questions whether they come from a sheet or not” (Rose et al 2000). The comments of 
another informant highlight the same problem: ”Physicians should listen more to their 
patients. They are usually in a hurry, and they renew prescriptions and say ‘see you 
later’ at the same time. Likewise, the nurses wash and oil their hands, waiting the 
patient to get out quickly. They could at least ask ‘how are you’ or something like that” 
(Uusitalo 1998). 
 
Offering information sources  
   For overall treatment, it is also important that patients receive written material of high 
quality. In Great Britain, out of nineteen patient information leaflets, none presented all 
the information considered important (Fitzmaurice and Adams 2000). 68% of the 
leaflets did not explain hypertension in the context of the overall risk of cardiovascular 
diseases. The corresponding percentages were 63% for measuring blood pressure and 
58% for the importance of regular monitoring. Some patients may think they are 
compliant even if they are not, the reason being that they have not been given adequate 
instructions about their treatment (Kyngäs et al. 2000). 
   It seems that, in the health care system, there would be a need to develop methods that 
offer more information to the patients about their diseases. An example of this is 
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Hyvinkää hospital in Finland, where a patient education center offers information about 
different diseases and their treatment in the form of books, brochures, videos, cd-roms, 
journals and on-line information (Välimäki et al 2002). 
 
 
2.2.3 Non-compliance and the patient 
 
Age and gender 
   Several studies have shown an association of non-compliance with younger age (Shaw 
et al. 1995, Wallenius et al. 1995, Bailey et al. 1996, Bloom 1998, Degli Esposti et al. 
2002). Some other studies have not shown an association (Mallion et al. 1996, Patel and 
Taylor 2002).  
   Most studies have not found any association between gender and compliance (Shaw et 
al. 1995, Wallenius et al. 1995, Bailey et al. 1996, Mallion et al. 1996, Monane et al. 
1996, Patel and Taylor 2002). 
 
Education and economic factors 
   The results of several studies also suggest that general education is not associated with 
compliance (Richardson et al. 1993, Shaw et al. 1995, Patel and Taylor 2002). 
   The association between compliance and income does not seem to be so clear. One 
study on US hypertensive patients did not find an association between compliance and 
family income (Patel and Taylor 2002). However, another study on US hypertensive 
patients found an association between intentional non-compliance and economic 
problems in buying medicines (Shaw et al. 1995). The same study also revealed 
compliance to be poorer among employed than unemployed people. However, a third 
study from the United States on hypertensive patients’ employment situation showed no 
association with compliance (Richardson et al. 1993). 
 
Perceptions of hypertension 
   To understand better our hypertensive patients, we should become familiar with their 
views about hypertension. A US study on 102 hypertensive patients assessed patients’ 
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views about the reasons for their hypertension by using 17 items (Patel and Taylor 
2002). These reasons include several modifiable reasons shown to be associated with 
hypertension, such as obesity, inadequate aerobic exercise, too much salt in the diet, too 
much coffee or alcohol (Table 3) (Midgley et al. 1996, Halbert et al. 1997, The Trials of 
Hypertension Prevention Collaborative Research Group 1997, Jee et al 1999, Xin et al 
2001, Whelton et al. 2002). However, these reasons also include some personal views 
about the causes of hypertension. 
 
Table 3. Patients’ views about the causes of his/her hypertension (Patel and Taylor 
2002). 
 
Reason Prevalence (%) 
Family history  57 
Obesity  42 
Stress from work  41 
Not enough exercise  37 
General tension and nervousness  30 
Stress at home  30 
Eating the wrong foods  29 
Too much salt in diet  22 
Age  20 
Another disease  17 
Gender  16 
Too much caffeine  13 
Alcohol  12 
Smoking  8 
Will of God  7 
Fate  6 
Bad luck  5 
 
   When a patient and a health care professional discuss, it is possible that they do not 
even discuss the same disease. In a US study on 60 African-American women with 
hypertension, half of the patients thought that there are two separate diseases: high 
blood and high-pertension, which are related to each other (Heurtin-Roberts and Reisin 
1992). In high blood, the level of blood pressure was thought to fluctuate only slightly 
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overs weeks or months. Suitable treatment of this disease was thought to be diet and 
antihypertensive drugs. In high-pertension, on the other hand, blood pressure was 
thought to rise suddenly, and the course of the disease was regarded as unpredictable 
and more dangerous than in high blood. The best treatment methods were to avoid 
worries, relaxing, resting and staying quiet, whereas antihypertensive drugs were not 
thought to be very useful. Patients have also reported that they do not like medicines, or 
that they find them unnatural and prefer to use home remedies (e.g. garlic) instead of 
antihypertensive drugs (Shaw et al. 1995, Svensson et al. 2000). Furthermore, the 
reasons for non-compliance may be associated with many other cultural and attitudinal 
factors (Delgado 2000). 
 
Role of patient knowledge 
   Good knowledge about hypertension is an essential part of successful treatment, but 
unfortunately, it seems that we are far from an optimal situation in many cases. A 
Finnish study on 623 hypertensive patients from a private clinic showed that 42% of the 
patients, according to their own opinion, had not received enough information about the 
adverse effects of antihypertensive drugs, and about every fifth had not received enough 
information about the duration of antihypertensive medication (Enlund et al 1991). 
   A Swedish study on 33 hypertensive patients also showed deficiencies in patients’ 
knowledges about the effects of antihypertensive drugs (Kjellgren et al 1998). 39% did 
not know anything about their mechanism of action. Some patients described the 
mechanism as follows: they keep the blood pressure down (33%), the diuretic decreases 
the amount of fluid/oedema in the body (21%), the drug dilates blood vessels (18%). 
There were also rare answers of the following kinds: they are beta blockers, slows/calms 
down the heart, makes blood thinner / prevents it from clotting, makes blood flow 
better, makes the vessels hold, protect the kidneys, have some effect on the heart, affect 
the velocity of blood, is tranquillising. In another Swedish study, part of hypertensive 
patients perceived the information on medicines as difficult to understand (Lisper et al 
1997). An Australian study on 84 hypertensive patients and 58 normotensive controls, 
adjusted according to age, gender and education, showed that there were no differences 
in the knowledge of hypertension between the groups (Carney et al 1993). The same 
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study also showed that older people had less knowledge about hypertension than 
younger ones. Furthermore, 57% of hypertensive patients were satisfied with their 
current knowledge, but 70% wanted more information about hypertension.  
 
Home blood pressure measurements 
   Several studies suggest that home blood pressure measurements may improve 
compliance. In a large Japanese study on 777 patients who had a home blood pressure 
measurement device, compliance was better among those who measured their blood 
pressure daily than among those who did not measure it at all (Ashida et al. 2000). In 
another study carried out in Belgium, some patients received a home blood pressure 
measurement device and were asked to measure their blood pressure every morning 
(Smith and Diggle 1998). Compliance was better among those who used their home 
blood pressure measurement device than among those who did not use it. A study from 
Switzerland showed that 65% of hypertensive patients were compliant before and 81% 
after they received a home blood pressure measurement device (Edmonds et al. 1985).  
 
Lifestyle 
   Irregular lifestyle, disturbances of every day life and the fact that patients do not take 
the medicines with them when they leave home for more than a day have also been 
reported as reasons for non-compliance (Balazovjech and Hnilica 1993, Shaw et al. 
1995, Dusing et al. 1998). Worries about pride and not wanting to look weak or non-
macho have been reported as reasons for not seeking help from professionals or close 
persons (Rose et al. 2000). 
 
Other factors  
   In several studies, patients have reported the reason for non-compliance being 
forgetfulness (Cooper et al. 1982, Balazovjech and Hnilica 1993, Dusing et al. 1998). 
Some patients have reported misunderstandings as a reason for their non-compliance 
(Cooper et al. 1982). Depression has also been found to explain part of non-compliance 
with antihypertensive medication (Wang et al. 2002).  
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Reasons for good compliance  
   In clarifying the roots of non-compliance, it is also good to look closer at the factors 
that lead to good compliance. In a Swedish study of 33 hypertensive patients, the 
following reasons for complying were reported: trust in physicians (decisions 
concerning medication are best left to professionals), avoidance of complications of 
hypertension (stroke, heart attack, death, etc.), need to control blood pressure readings, 
avoidance of symptoms of hypertension (headache, palpitations, poor health, fatigue), 
lack of adverse drug effects and acceptance of disease (Svensson et al. 2000). In another 
study, nine out of ten patients reported their reason for taking antihypertensive 
medication to be a desire to achieve some good results (Benson and Britten 2003). 
 
 
2.3 Problems related to the medical treatment of hypertension 
2.3.1 Hypertension as a public health problem 
 
   The Finnish guidelines classify blood pressure as elevated when systolic blood 
pressure is 140 mmHg or higher or diastolic blood pressure is 90 mmHg or higher 
(Suomen Verenpaineyhdistys 2002). However, this classification does not take into 
account the phenomenon of hypertension. Blood pressure in the population is 
continuous and distributed nearly according to the Gaussian curve, which means that 
there are no two separate groups of persons with normal or high blood pressure 
(Beevers et al. 2001b). Thus, the prevalence of high blood pressure depends on where 
the line between normal and high blood pressure is drawn (Hansson et al. 2000). The 
distribution of blood pressure, particularly in the older population, is slightly skewed to 
the right, and if the same limit for hypertension is used, there will be a higher 
prevalence in this population compared to the younger population (Hansson et al. 2000).  
   Blood pressure is associated directly and continuously without any threshold level 
with coronary heart disease and stroke in persons with no previous serious 
cardiovascular disease (Collins and MacMahon 1994). It was shown recently that 
elevated blood pressure even in young adulthood predicted long-term mortality due to 
cardiovascular diseases, coronary heart disease and all causes (Miura et al. 2001).  
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Costs of treatment 
   In Finland, more than 9% of the population have special reimbursement for 
antihypertensive medications (Klaukka 2002). In the age group of over 65 years the 
prevalence was 32% and in the working age population about 6% (Klaukka 2002). The 
most recent statistics of the year 2004 show the number of hypertensive population to be 
499.658 patients (Klaukka 2005). Hypertension has been the leading cause of special 
reimbursement for years. The number of patients with special reimbursement for 
antihypertensive medication increased from 438.895 in 1995 to 484.563 in 2002, i.e. by 
altogether about 45 700, and the costs of special reimbursements for Social Insurance 
Institution increased by over 34 million euros (Rajaniemi 1996, 2003). If the cost of 
special reimbursement per patient had been at the same level in 2002 as it was in 1995, 
the cost of special reimbursement in 2002 would have been only 78 million euros as 
compared to the 105 million euros in reality. Furthermore, there are also other costs 
incurred by Social Insurance Institution and the patients due to the treatment of 
hypertension. The main reason for the increase in to costs of medicines is the 
replacement of older medicines with newer ones, which often involves additional costs 
(Klaukka 2001). However, the treatment benefits of the newer medicines are often quite 
small, and knowledge about their safety in long-term use is quite scarce (Klaukka 
2001). Unnecessary costs may also result from non-rational prescription of drugs or 
non-compliance (Enlund and Poston 1987). Therefore, it is important to prevent 
unnecessary costs and use adequate and effective treatments to reach the goals of 
hypertension treatment. It has been estimated that, in France, Germany, Italy, Sweden 
and Great Britain, health care costs of 1.26 billion euros could be avoided if the target 
levels of blood pressure were reached (Hansson et al. 2002). 
 
 
2.3.2 Outcomes of treatment 
 
   The Finnish national study of hypertensive patients in primary health care in 2002 
indicated that 78 % of men and 74 % of women had blood pressure that was higher than 
the target level (maximum target level 140/85 mmHg) (Meriranta et al. 2004). In a 
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corresponding national study carried out in the years 1996-1997, 81 % of men and 80 % 
of women had blood pressures higher than the target level (which was 140/90 mmHg 
according to the older criteria) (Takala et al. 2001).  
   In 1997, population samples of 25- to 64-year-olds from Northern Karelia, Kuopio, 
south-western Finland and Helsinki-Vantaa region showed that the mean systolic blood 
pressures in men ranged from 135 to 138 mmHg and those in women from 128 to 132 
mmHg, and the corresponding diastolic blood pressures in men were 83 to 85 mmHg 
and those in women 80 mmHg (Kastarinen et al. 1998). From 1982 to 1997 in Northern 
Karelia, Kuopio and south-western Finland, systolic blood pressure in men decreased by 
6-7 mmHg and that in women by 7-10 mmHg. Diastolic blood pressure also decreased 
in Northern Karelia and Kuopio by 2 to 3 mmHg in men and by 3 to 4 mmHg in 
women, while there was no change in south-western Finland. Furthermore, the study 
showed that the age-adjusted prevalence of hypertension (systolic blood pressure > 140 
mmHg or diastolic blood pressure > 90 mmHg or antihypertensive medication) had 
decreased in Northern Karelia and Kuopio by 16 to 18 percentage points in men and by 
13 to 15 percentage points in women. The corresponding figures in south-western 
Finland were 11 percentage points for men and 9 percentage points for women.  
   The national NHANES III study in the United States estimated that 41.9 million 
(27%) of the population aged 25 years old or over had hypertension (Hyman and Pavlik 
2001). Furthermore, 31% of them were unaware of their hypertension, and only 23% 
both had medical treatment for their hypertension and had reached a blood pressure 
under 140/90 mmHg. Erdine (2000) also reported that only 4 to 33 % of hypertensive 
patients in nine European countries had blood pressure readings lower than 140/90 
mmHg. A Scottish study showed that, especially in men, the control of blood pressure is 
accordant with the rule of halves, which means that hypertension goes undetected in 
half of patients, hypertension remain untreated in half of the rest, and hypertension 
remains uncontrolled in half of the rest (Smith et al. 1990). 
 
Starting and continuing of antihypertensive treatment 
   Several studies have shown that, after starting antihypertensive medication, the 
problem is that many hypertensive patients stop taking their medications. In a study in 
43 
the United States, nearly 22.000 patients who started antihypertensive medication for 
the first time were followed up for 12 months (Bloom 1998). In all of the five drug 
groups, 6 to 9% of patients changed the antihypertensive drug first prescribed to them to 
a drug from another group. The percentages of discontinuation were: 29% for 
angiotensin II antagonists (losartan), 33% for ACE inhibitors, 41% for calcium channel 
blockers, 50% for beta-blocking agents and 56% for thiazide diuretics. The results of 
the angiotensin II antagonists group should be approached with caution because all the 
other groups where about ten times larger. 
   A study from Great Britain on more than 7.700 patients of 40 years or more of age, 
who had been recently diagnosed as hypertensive and had started at least one 
antihypertensive drug, showed that 15 to 16% of the patients on calcium channel 
blockers, ACE inhibitors and diuretics and 21% of those on beta-blocking agents had 
changed their medication during the first six months (Hughes and McGuire 1998). 
Furthermore, 28% of the patients on beta-blocking agents, 31% of those on ACE 
inhibitors and calcium channel blockers and 36% of those on diuretics had stopped 
taking their medication during the first six months. 
   In an Italian study on nearly 17.000 patients of 20 years or more of age, who started 
their antihypertensive drug for the first time, the continuation of medication use was 
followed up for 9 months (Degli Esposti et al. 2002). Altogether 42% of the patients on 
angiotensin II antagonists (losartan), 60% on ACE inhibitors, 62% on beta-blocking 
agents, 69% on calcium channel blockers and 70% on diuretics stopped their 
medication. Furthermore, 7 to 9% of the patients in the different drug groups, except 
25% in the angiotensin II antagonists group, changed their drug to another 
antihypertensive drug during the follow-up period.  
 
 
2.4 Summary of the literature 
 
   Modern medicine has struggled against non-compliance for over half a century. A 
huge number of non-compliance studies have been produced, but we still face enormous 
problems of non-compliance. We know that non-compliance is very common and 
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potentially present in practically every medical treatment. We have several methods for 
measuring non-compliance, but nobody has been able to create a standardized method 
that would produce reliable results. Research has been able to recognize several factors 
associated with non-compliance, but our possibilities to improve compliance are very 
limited. 
   We know that non-compliance is associated with poor treatment outcomes in many 
diseases, including hypertension. The high discontinuation rates of antihypertensive 
medications, at least in the early stages of treatment, have been found to be more than 
alarming. On the other hand, hypertension research has been able to recognize several 
factors associated with poor blood pressures, but today, only a minority of hypertensive 
patients reach the target levels of blood pressure in Finland as well as in many other 
countries. 
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3 AIMS OF THE STUDY 
 
   The principal purpose of this study was to investigate the phenomenon of non-
compliance and patient-perceived problems mainly from the viewpoint of hypertension.   
   The specific aims of the study were: 
 
1. To describe the prevalence of different perceived problems and attitudes in the 
treatment of hypertension. 
2. To evaluate the association of perceived problems and attitudes with non-
compliance with antihypertensive drug therapy. 
3. To evaluate the association of perceived problems and attitudes as well as non-
compliance with the control of blood pressure with antihypertensive drug therapy. 
4. To create a theoretical model to classify and understand non-compliance.  
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4   STUDY POPULATIONS AND METHODS 
 
4.1 Study populations 
4.1.1 Pharmacy-based study population (I) 
 
   The study population was recruited in five pharmacies in Oulu (112.000 inhabitants) 
between May and August 1996 and four pharmacies in Tampere (186.000 inhabitants) 
between August and September 1996. To be eligible to participate in the study, the 
patients had to fulfil the following criteria: born in the year 1921 or later, buying 
antihypertensive medication for himself/herself and entitled to receive special 
reimbursement for antihypertensive medication under the national sickness insurance 
program.  
   Of the patients invited to participate (n = 971), 105 refused and 866 agreed and 
received a questionnaire to be completed at home (Figure 1).  Fifty-six percent (482 
patients) filled in the questionnaire. Of the respondents, 54 were excluded from the 
analyses due to missing data on at least one variable. Thus, the final study population 
consisted of 428 patients, 199 (46.5  %)  men and 229 women (53.5 %), with a mean 
(+SD) age of 58.4 + 10.5 years (Table 4). The mean self-reported systolic and diastolic 
blood pressures were 149.9 + 17.6 and 89.5 + 8.9 mmHg. The mean number of 
antihypertensive drugs was 1.7 + 0.7. 
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Table 4. Characteristics of the pharmacy-based study population (n = 428). 
 
 Men Women Total 
Characteristic n % n % n % 
Age       
  < 50 years 47 24 41 18 88 21 
  50 – 64 years 104 52 98 43 202 47 
  65 – 75 years 48 24 90 39 138 32 
Education       
  primary 75 38 126 55 201 47 
  secondary 97 49 87 38 184 43 
  academic 27 14 16 7 43 10 
Years of treatment       
  < 5 45 23 48 21 93 22 
  5 – 9 57 29 47 21 104 24 
  10 – 19 56 28 64 28 120 28 
  > 20 41 21 70 31 111 26 
Number of antihypertensive drugs       
  1 96 48 100 44 196 46 
  2 75 38 103 45 178 42 
  3 – 5 28 14 26 11 54 13 
 
 
4.1.2 Primary health care based study population (II, III, IV) 
 
  The Finnish national study of hypertensive patients in primary health care in 1995 
identified a very high number (89%) of medically treated hypertensives whose blood 
pressure was not controlled (not below 140/90 mmHg)  (Kumpusalo et al. 1997). These 
findings motivated the initiation of a new study on the treatment situation and problems 
in hypertension care in 1996-1997. 
   The study was approved by the Review Board of Kuopio University Hospital. Thirty 
health centres out of the a total of 250 health centres in Finland were randomly selected 
by stratified sampling as representative of the basic population in terms of size and 
geographical location. Twenty-six health centres with a total of 255 general 
practitioners agreed to participate in the study. During one week in November 1996, 
these general practitioners identified all of the hypertensive patients who visited them (n 
= 2.219), excluding after-hours consultations (Figure 1). During the following three 
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months, public health nurses sent to these patients two questionnaires and an invitation 
to a health examination. 
   A total of 1.782 patients filled in and returned their questionnaires and participated in 
the health examination (80%). At the health examination a trained public health nurse 
checked any missing data in the first questionnaire. The second questionnaire, which 
contained confidential data on the local doctors, nurses and health care system, was 
handed to the nurse in a closed envelope to be mailed to the university. One patient was 
excluded from the study because of missing data on most questions. Our main emphasis 
was on the medically treated population consisting of 1.561 patients, 615 (39.4%) men 
and 946 (60.6%) women, with a mean (+SD) age of 64.2 + 11.4 years (Table 5). The 
mean systolic and diastolic blood pressures were 152.8 + 19.9 and 88.2 + 10.1 mmHg. 
Eighty-four per cent of the patients had at least three blood pressure readings from the 
year 1996 and the early part of 1997. In these measurements, the patients had had mean 
systolic and diastolic blood pressures 2.6 + 15.8 and 1.5 + 8.3 mmHg higher than their 
current blood pressure readings. Furthermore, the mean number of antihypertensive 
drugs was 1.6 + 0.7. The prevalence of patient-perceived problems analyses were also 
carried out on the medically untreated population, which consisted of 220 patients, 90 
(40.9%) men and 130 (59.1%) women, mean age 59.8 + 11.7 years. Their mean systolic 
and diastolic blood pressures were 154.1 + 18.1 and 91.5 + 10.4 mmHg, respectively. If 
the systolic and diastolic blood pressure values had been calculated based on the smaller 
of the two recorded readings, the respective values would have been 149.5 + 19.6 and 
86.8 + 10.2 mmHg for the medically treated population and 150.5 + 18.2 and 90.0 + 
10.8 mmHg for the medically untreated population. 
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Table 5. Characteristics of the primary health care based study population (n = 1561). 
 
 Men Women Total 
Characteristic n % n % n % 
Age       
  < 55 years 144 23 186 20 330 21 
  55 – 64 years 183 30 224 24 407 26 
  65 – 74 years 217 35 308 33 525 34 
  > 75 years 71 12 228 24 299 19 
Education       
  lowera 431 71 739 79 1170 75 
  higherb 180 29 200 21 380 25 
Duration of hypertension       
  < 5 years 166 27 228 24 394 25 
  5 – 9 years 134 22 186 20 320 21 
  > 10 years 312 51 525 56 837 54 
Number of antihypertensive drugs       
  1 331 54 462 49 793 51 
  2 223 36 375 40 598 38 
  3 – 5 59 10 105 11 164 11 
a basic school, junior secondary school, primary school or parts of these curricula 
b academic education, occupational school, vocational school, senior secondary school 
 
 
Pharmacy-based study population      Primary health care based study population 
 
971  Were invited to participate      2219  Were invited to participate 
 
                105 Refused to participate                            437 Did not participate 
 
866  Agreed to participate                             1782   Participated 
 
                384 Did not return the                                  1 Was excluded due to 
                       questionnaire                                            missing data 
482  Returned the questionnaire                   1781 Study population with adequately 
                        filled questionnaires 
                54 Were excluded due to                              220 Medically untreated  
                     missing data         population 
428  Final study population                           1561 Final study population 
 
Figure 1. Pharmacy-based and primary health care based study populations.  
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4.2 Methods in the primary health care based studies (II, III, IV) 
 
   At the health examination, blood pressure was measured by trained health nurses 
twice after a 15-minute rest in a sitting position using a mercury sphygmomanometer 
according to the international MONICA protocol. The mean value of these two readings 
was used in the statistical analyses. 
   The two questionnaires included a total of 82 questions about lifestyle, health care 
system, medication, blood pressure measurements and the patient’s experiences related 
to the treatment of hypertension. These areas were identified from the literature as being 
critical for good hypertension care. The original questions were answered on a five-
point Likert scale (1 = absolutely agree, 2 = somewhat agree, 3 = somewhat disagree, 4 
= absolutely disagree, 5 = does not concern me) or a three-point scale (14 questions: 1 = 
correct, 2 = not correct, 3 = does not concern me). Using factor analysis with varimax 
rotation on these 82 questions, 21 factors were identified (eigenvalue of > 1.0 was used 
as the cut-off point). Four factors, including aspects of nonpharmacological treatment of 
hypertension, such as weight reduction (three factors) and use of salt, were excluded. 
The questions in the factors were dichotomized as 1 (those with a problem: absolutely 
agree, somewhat agree, and correct) and 0 (those without a problem: somewhat 
disagree, absolutely disagree, not correct, does not concern me, and missing data). On 
the basis of reliability and internal validity analyses, some questions and four of the 
factors were excluded. One factor was split because of its poor internal validity, and a 
total of 14 problem areas covered by 45 questions were thus identified. These questions 
were summed up to construct 14 indices (two to six items in each). 
 
 
4.3 Variable definitions 
4.3.1 Variable definitions in the pharmacy-based study (I) 
 
Patient-perceived problems 
   Perceived problems in the treatment of hypertension were assessed by a series of 
seven questions. Experiences concerning the symptoms of hypertension and adverse 
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drug effects were elicited by asking the patient whether his/her hypertension (or drug 
treatment) had caused any symptoms (adverse effects). We assessed the perceived 
difficulties to be hypertensive by asking whether the patient felt it was difficult to be a 
patient with hypertension. Perceived memory problems were assessed by asking 
whether it was difficult to remember to take antihypertensive drugs. The patients were 
also asked whether they had had to give up any pleasant activities due to hypertension.  
Finally, they were asked whether hypertension or drug taking had interfered with their 
daily routines and hobbies. The number of problems was defined as the sum of positive 
responses to the above seven questions.  The patients were then classified into one of 
four categories:  having no problems, one, two and three or more problems.  
 
Non-compliance 
   Self-initiated modification of dosage instructions was assessed by asking whether the 
patient had ever tried to manage with less antihypertensive drugs than those prescribed.  
The subjects were offered three possible responses: “often”, “sometimes” and “no”.  
Those selecting "often" or "sometimes" were classified as modifiers and those 
answering "no" as nonmodifiers.  Since previous research (Enlund 1982) had shown that 
underuse of drugs is the major problem in the treatment of hypertension, while overuse 
is rare, we based our definition of modification on the reported underuse of 
antihypertensive drugs. 
 
Blood pressure 
   The outcome of antihypertensive treatment was operationalized as the patient's blood 
pressure level. Information on each patient's blood pressure level was obtained by 
asking the patient to report the blood pressure reading from the latest measurement 
conducted by a nurse or a physician.  This method was considered feasible, since most 
hypertensive patients in Finland carry a personal blood pressure card including this 
information. The pharmacy-based study population was divided into two groups based 
on blood pressure values: (i) those having systolic blood pressure of less than 160 
mmHg and diastolic blood pressure of less than 90 mmHg and (ii) those not reaching 
this blood pressure level. 
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4.3.2 Variable definitions in the primary care based studies (II, III, IV) 
 
Prevalence of patient-perceived problems and attitudes (II) 
   For the purpose of describing the prevalence of different patient-perceived problems 
and attitudes in the treatment of hypertension, the 14 problem indices were 
dichotomized as 0 and 1+ in such a way that one positive answer to the original 
questions indicated a problem.  
 
Adverse effects (III, IV) 
   The patients were also asked whether their current antihypertensive medication had 
caused any adverse effects. The patients with missing data were classified as having no 
adverse effects. By combining this question and the ”adverse effects of hypertension 
treatment on sexual functions” sum variable (one of the 14 indices), the adverse drug 
effect variable was formulated. It was dichotomized as 0 and 1+ in such a way that one 
positive answer to the original questions indicated an adverse drug effect.  
 
Non-compliance (III, IV) 
   The variable ”Self-reported non-compliance” was based on whether the patient 
admitted to having taken his/her antihypertensive medication less often than prescribed 
during the last year (prevalence 8.3%) and the ”modification of dosage instructions” 
sum variable (prevalence 7.5%) of four items (one of the 14 indices). These items were: 
“I have tried to save money also by diminishing the use of antihypertensive 
medication”, “The pharmacy staff have paid attention to that I don’t use my 
antihypertensive medication exactly as prescribed”, “I haven’t taken my 
antihypertensive medication recently, and they haven’t paid any attention to it in the 
health centre” and “They have paid attention to my irregular use of antihypertensive 
medication in the health centre”. 
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Blood pressure (IV) 
   The study population was divided into two groups based on blood pressure values: (i) 
those having systolic blood pressure of less than 140 mmHg and diastolic blood 
pressure of less than 90 mmHg and (ii) those not reaching this target goal.  
 
 
4.4 Data analysis 
4.4.1 Data analysis in the pharmacy-based study (I) 
 
   The factors potentially associated with the modification of dosage instructions and the 
blood pressure level were subjected to multiple logistic regression analyses. The model 
with modification as the dependent variable included the following independent 
variables (the reference category is mentioned first): gender (female, male), age (65-75, 
50-64, <50 years), education (primary, secondary, academic), number of 
antihypertensive drugs (1, 2, 3-5), length of treatment (<5, 5-9, 10-19, >20 years) and 
number of problems (0, 1, 2, 3+). A similar model was fitted with blood pressure level 
as the dependent variable. Those with diastolic blood pressure of less than 90 mmHg 
and systolic blood pressure of less than 160 mmHg comprised the reference group. In 
addition, one multiple logistic regression model was fitted to examine the relationship 
between blood pressure level and the previously listed variables plus modification, and 
one model included all the other independent variables except the number of problems.  
The models that did not include the number of problems and modification as 
explanatory variables at the same time were fitted, since modification can be seen as an 
intervening variable between perceived problems and blood pressure level. Statistical 
analyses were performed using the SPSS software. P values of less than 0.05 were 
considered statistically significant in all analyses. 
54 
4.4.2 Data analysis in the primary care based studies (III, IV) 
 
Preparations for logistic regression analyses 
   The following six indices were classified as ”Perceived health care system related 
problems”: lack of follow-up by health centre (four items), perceived lack of 
information (three items), perceived lack of support by health care personnel (six items), 
problems with the practical aspects of hypertension care (two items), problems with 
scheduling blood pressure measurements (two items) and lack of special reimbursement 
for medication (two items). Likewise, the following six indices were classified as 
”Patient-related problems”: difficulties to accept being hypertensive (four items), 
careless attitude towards hypertension (five items), hopeless attitude towards 
hypertension (two items), perceived tension with blood pressure measurement (two 
items), perceived economic problems (four items) and frustration with treatment (three 
items). The indices were re-coded as 0 (low), 1 (medium), 2(+) (high number of) 
problems. The associations of these indices with the dependent variables were studied 
by using linear-by-linear associations of chi-square tests. 
   When non-compliance was the dependent variable, all of these indices except 
perceived tension with blood pressure measurement (p = 0.21) were associated with 
non-compliance at p < 0.001 level. Therefore, perceived health care system related 
problems and patient-related problems variables were formed by summing up the 
indices that were classified as belonging to these entities. Finally, both summary 
variables were re-coded by quartiles as a low (0-1), medium (containing the two middle 
quartiles) (2-4) and high (5-12) number of problems.  
   When poor blood pressure control was respectively used as the dependent variable, 
only three variables were associated with poor blood pressure at p < 0.10 level. These 
variables were hopeless attitude towards hypertension (p = 0.006), perceived tension 
with blood pressure measurement (p = 0.020) and frustration with treatment (p = 0.004). 
These three indices were also included in the multivariate analyses. 
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Logistic regression interaction analyses 
   The logistic regression model with non-compliance as the dependent variable included 
the following independent variables (the reference category is mentioned first): gender 
(female, male), age (<55, 55-64, 65-74, >75 years), education (lower: basic school, 
junior secondary school, primary school or parts of these curricula; higher: academic 
education, occupational school, vocational school, senior secondary school), number of 
antihypertensive drugs (1, 2, 3-5), duration of hypertension (<5, 5-9, >10 years),  
perceived health care system related problems (low, medium, high), patient-related 
problems (low, medium, high) and adverse drug effects (no, yes). 
   The respective model with blood pressure control as the dependent variable included 
the following independent variables (the reference category is mentioned first): gender 
(female, male), age (<55, 55-64, 65-74, >75 years), education (lower: basic school, 
junior secondary school, primary school or parts of these curricula; higher: academic 
education, occupational school, vocational school, senior secondary school), number of 
antihypertensive agents (1, 2, 3-5), duration of hypertension (<5, 5-9, >10 years), 
hopeless attitude towards hypertension (low, medium, high), perceived tension with 
blood pressure measurement (low, medium, high), frustration with treatment (low, 
medium, high), adverse drug effects (no, yes), and self-reported non-compliance 
(compliant, non-compliant). 
   To clarify possible interactions, we also performed logistic regression interaction 
analyses. These analyses included all the possible two-way interactions between the 
variables (28 in the compliance model and 45 in the blood pressure model). 
Furthermore, we included in the analyses the three-way interactions that had at least 10 
observations in each cell (none in the compliance model and 3 in the blood pressure 
model). The inclusion of 4-way interactions was not feasible because of the small 
number of observations in the cells. First, we excluded from the model the interactions 
whose 95% confidence intervals were too wide. After that, we excluded from the model 
one by one all the variables with p-values higher than or equal to 0.10 and all the 
interactions whose overall test of the categories was non-significant (p>0.05) based on 
the highest p-value. The basic variables of age and gender were not excluded from the 
models in any case. The main effects of the variables were not excluded when their 
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interactions were included in the model. Respectively, 2-way interactions that were 
included in any 3-way interactions were not excluded.  
   The final compliance interaction model contained only one interaction ”education” x 
”number of antihypertensive drugs”. Only one variable, i.e., the duration of 
hypertension, was non-significant or not part of any interaction and was therefore 
removed from the model. This model did not change appreciably the results of the other 
variables in the model.  
   Respectively, the final blood pressure interaction model contained only one 
interaction ”gender” x ”compliance”. Two variables, i.e., adverse drug effects and 
education, were non-significant and not part of any interaction and were therefore 
removed from the model.  
   Statistical analyses were performed using the SPSS software. However, the odds 
ratios and 95% confidence intervals for the interaction calculations were based on the 
method presented by Hosmer and Lemeshow (1989). P values less than 0.05 were 
considered statistically significant in all analyses. 
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5   RESULTS 
 
5.1 Perceived problems and attitudes in the treatment of hypertension (I, II) 
 
Results from the pharmacy-based study  
   The prevalence of different problems related to high blood pressure ranged from 8%  
to 36% of the study population (Table 6). Every third patient had experienced both 
symptoms of high blood pressure and adverse drug effects and, furthermore, held the 
view that it is difficult to be a patient with hypertension.  
 
Table 6. Proportion of study population reporting different problems with hypertension / 
antihypertensive treatment. 
 
 n % 
Symptoms of high blood pressure 414 36 
Adverse drug effects 409 32 
Perceived difficulties to be a hypertensive patient 421 31 
Perceived memory problems 428 17 
Interference with daily routines 426 13 
Had to give up pleasant activities due to hypertension / treatment 426 9 
Interference with hobbies 428 8 
 
Results from the primary health care based study  
   The most common problem for patients with hypertension was the lack of follow-up 
by the health centre (72%) (Table 7). The majority of this problem was based on 
patients perceptions that the visits to a nurse or a doctor because of hypertension had 
remained at the patient’s own discretion. Difficulties to accept being hypertensive 
(66%) were also common, but decreased with age among both men and women. A 
careless attitude towards hypertension (63%) increased with age among women, being 
highest among those 75 years or older. In addition, 56% of the patients perceived a lack 
of information concerning hypertension. This was more common among women than 
among men. Of the medically untreated patients, fewer expressed a need for more 
information (41%). 
    
 Table 7. Attitudes and perceived problems in antihypertensive treatment (% of patients). 
 
 Medically treated patients Medically 
  untreated 
 < 55 yrs. 55-64 yrs. 65-74 yrs. > 75 yrs. Total patients 
 (men n = 144) (men n = 183) (men n = 217) (men n = 71) (men n = 615) (men n = 90) 
 (women n = 186) (women n = 224) (women n = 308) (women n = 228) (women n = 946) (women n = 130) 
Lack of  follow-up by health centre      
 Men 67 68 74 70 70 80 
 Women 79 74 71 73 74 79 
Difficulties to accept being hypertensive      
 Men 79 71 65 54 69 60 
 Women 75 64 64 57 65 65 
Careless attitude towards hypertension      
 Men 56 61 65 56 61 59 
 Women 57 55 68 79 65 59 
Perceived lack of information 
 Men 49 52 52 55 52 39 
 Women 64 60 57 58 59 43 
Hopeless attitude towards hypertension 
 Men 34 21 22 30 26 10 
 Women 32 40 41 36 38 16 
Adverse effects of hypertension treatment on sexual functions 
 Men 42 55 58 41 51 11 
 Women 31 29 19 8 21 1 
Perceived lack of support by health care personnel 
 Men 28 27 28 25 27 32 
 Women 43 28 29 36 33 29 
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 Table 7. continues. 
 
 Medically treated patients Medically 
  untreated 
 < 55 yrs. 55-64 yrs. 65-74 yrs. > 75 yrs. Total patients 
 (men n = 144) (men n = 183) (men n = 217) (men n = 71) (men n = 615) (men n = 90) 
 (women n = 186) (women n = 224) (women n = 308) (women n = 228) (women n = 946) (women n = 130) 
Perceived tension with blood pressure measurement     
 Men 21 21 21 13 20 20 
 Women 35 29 29 29 30 25 
Perceived economic problems      
 Men 38 30 28 20 30 12 
 Women 23 22 22 20 22 15 
Frustration with treatment      
 Men 32 20 16 24 22 14 
 Women 30 24 22 27 25 19 
Problems with practical aspects of hypertension care 
 Men 18 17 18 18 18 21 
 Women 30 24 20 24 24 25 
Problems with scheduling blood pressure measurements 
 Men 31 19 12 21 20 14 
 Women 38 21 13 17 21 27 
Lack of special reimbursement for medication 
 Men 12 9 12 11 11 3 
 Women 12 8 10 14 11 2 
Modification of dosage instructions 
 Men 11 10 5 8 8 4 
 Women 5 9 6 7 7 3 
59 
60 
   Twenty-six percent of men and 38% of women felt hopeless about their hypertension. 
The respective figures for the untreated subjects being 10% for men and 16% for 
women. Among the medically treated men, the prevalence of a hopeless attitude 
towards hypertension was more common among those under 55 years old and over 74 
years old. Contrary to this, the women aged 55 to 74 years showed the highest level of 
hopelessness. 
   Fifty-one percent of men and 21% of women reported adverse effects of 
antihypertensive treatment on sexual functions. Among women, this prevalence 
decreased with age, while the highest prevalences among men occurred in those aged 55 
to 74 years. Among women, 33% perceived a lack of support by health care personnel, 
which was most common among those aged under 55 years old (43%). Among men, 
27% perceived a lack of support, with only minor differences between age groups. The 
prevalence of perceived economic problems was higher among men (30%) than among 
women (22%). Among men, perceived economic problems decreased with age, whereas 
no differences were seen among women. 
   The sum variable created out of the 14 problem variables received values from 0 to 
14. Almost all medically treated patients (98%) had one or more problems. The mean 
(+SD) number of problems was 4.8 + 2.6 for men and 4.9 + 2.5 for women. 
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5.2 Factors related to non-compliance with antihypertensive drug therapy (I, III) 
 
Results from the pharmacy-based study  
   Thirty-one percent of men and 21% of women reported modification of dosage 
instructions (Table 8). A total of  two-thirds (68 %) of the study population reported 
suffering from one or more problems. The proportion of modifiers was found to 
increase not only with an increasing level of education, but also linearly according to 
the number of problems experienced, from 12% for those without problems to 43% for 
those with three or more problems. Moreover, those with two problems were two times 
more likely and those with three or more problems were almost four times more likely 
to have modified their dosage instructions than those without problems.  
 
Table 8. Odds ratios (OR) and 95 % confidence intervals (CI) for factors associated 
with modification of dosage instructions. 
 
 
Factor 
 
n 
Modifier 
(%) 
OR 
 (95 % CI) 
Adjusted ORa 
 (95 % CI) 
Gender     
  male 199 31 1.67 (1.08, 2.58) 1.39 (0.86, 2.24) 
  female 229 21 1.00 1.00 
Age (years)     
  < 50 88 31 1.66 (0.90, 3.06) 1.54 (0.75, 3.17) 
  50 – 64 202 26 1.34 (0.80, 2.24) 1.22 (0.69, 2.17) 
  65 – 75 138 21 1.00 1.00 
Education     
  primary 201 18 1.00 1.00 
  secondary 184 29 1.84 (1.14, 2.97) 1.75 (1.04, 2.93) 
  academic 43 42 3.19 (1.58, 6.45) 2.69 (1.27, 5.70) 
Number of 
antihypertensive drugs  
    
  1  196 25 1.00 1.00 
  2  178 22 0.87 (0.54, 1.40) 0.92 (0.55, 1.54) 
  3 – 5  54 37 1.76 (0.93, 3.35) 1.29 (0.62, 2.66) 
Years in treatment     
  < 5 93 18 1.00 1.00 
  5 – 9 104 26 1.57 (0.79, 3.11) 1.75 (0.84, 3.64) 
  10 – 19 120 33 2.15 (1.12, 4.12) 2.27 (1.11, 4.65) 
  > 20 111 23 1.37 (0.69, 2.71) 1.84 (0.82, 4.14) 
Number of problems     
  0 137 12 1.00 1.00 
  1 112 23 2.29 (1.16, 4.52) 2.09 (1.04, 4.19) 
  2 96 32 3.61 (1.84, 7.08) 3.05 (1.51, 6.14) 
  3 + 83 43 5.79 (2.94, 11.42) 4.79 (2.36, 9.73) 
a adjusted for all other variables in the table 
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Results from the primary health care based study  
   Fourteen percent of men and 13% of women reported non-compliance with 
antihypertensive medication (Table 9). The majority of patients reported having one or 
more perceived health care system related problems (88%) and patient-related problems 
(92%). The proportion of non-compliant patients increased significantly along with the 
increasing number of perceived health care system related problems from 5% (low) to 
24% (high) (Table 9). A similar significant trend was also seen in patient-related 
problems from 5% to 21%. Those with high levels of perceived health care system 
related problems were almost four times more likely to be non-compliant. Moreover, 
those with high levels of patient-related problems were over two times more likely to be 
non-compliant. Patients who had experienced adverse drug effects were significantly 
more likely to be non-compliant (17%) than those without adverse drug effects (11%). 
   In the final interaction model, we identified two significant findings in the interaction 
(data not shown). In the patient group using two antihypertensive drugs, non-
compliance was less prevalent among the more highly educated than among the less 
educated (adjusted OR 0.50; 95% CI 0.26, 0.98). Further, among the patients with 
higher education, non-compliance was less prevalent in the group with two drugs than 
in that with one drug (adjusted OR 0.47; 95% CI 0.23, 0.97). 
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Table 9. Odds ratios (OR) and 95 % confidence intervals (CI) for factors associated 
with self-reported non-compliance (NC) in antihypertensive care. 
 
 
Factor 
 
n 
NC  
(%) 
OR 
 (95 % CI) 
Adjusted ORa 
 (95 % CI) 
Gender     
  female 930 13 1.00 1.00 
  male 606 14 1.06 (0.78, 1.42) 1.07 (0.77, 1.47) 
Age     
  < 55 years 327 16 1.00 1.00 
  55 – 64 years 403 17 1.10 (0.74, 1.63) 1.32 (0.86, 2.00) 
  65 – 74  years 515 11 0.69 (0.46, 1.03) 0.85 (0.54, 1.31) 
  > 75 years 291 10 0.62 (0.38, 1.01) 0.76 (0.45, 1.28) 
Education     
  lower 1159 13 1.00 1.00 
  higher 377 14 1.04 (0.74, 1.45) 0.97 (0.68, 1.40) 
Number of 
antihypertensive drugs  
    
  1  783 14 1.00 1.00 
  2  591 14 1.02 (0.75, 1.39) 0.96 (0.69, 1.33) 
  3 – 5  162 10 0.69 (0.39, 1.19) 0.68 (0.38, 1.23) 
Duration of hypertension     
  < 5 years 393 13 1.00 1.00 
  5 – 9 years 318 15 1.22 (0.80, 1.87) 1.09 (0.70, 1.70) 
  > 10 years 825 13 1.00 (0.70, 1.43) 1.06 (0.72, 1.57) 
Perceived health care 
system related problems 
    
  low 399 5 1.00 1.00 
  medium 735 13 3.06 (1.82, 5.14) 2.51 (1.48, 4.27) 
  high 402 24 6.62 (3.92, 11.20) 4.77 (2.76, 8.26) 
Patient-related problems     
  low 299 5 1.00 1.00 
  medium 753 12 2.57 (1.46, 4.51)  2.07 (1.16, 3.68) 
  high 484 21 5.05 (2.88, 8.86) 3.23 (1.79, 5.81) 
Adverse drug effects     
  No 869 11 1.00 1.00 
  Yes 667 17 1.64 (1.23, 2.21) 1.41 (1.03, 1.94) 
a adjusted for all other variables in the table 
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5.3 Factors related to poor control of blood pressure with antihypertensive drug 
therapy (I, IV) 
 
Results from the pharmacy-based study  
   Only 156 (36%) of the patients had blood pressure below 160/90 mmHg (Table 10). 
The proportion of those with poor blood pressure control increased linearly with the 
number of experienced problems from 57% for those without problems to 73% for those 
with three or more problems. This finding was statistically significant in the logistic 
regression model, which was adjusted for all the other variables except the modification 
of dosage instructions. When adjustment for modification was added to the model there 
were only minor changes in the odds ratios and 95% confidence intervals. However, this 
finding was no longer statistically significant. The effect of experienced problems on 
the outcome of antihypertensive treatment seems to be only partly mediated by 
modification of dosage instructions. Modification of dosage instructions was 
significantly associated with blood pressure levels regardless of whether the adjustments 
were done for all variables or all variables except the number of problems. 
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Table 10. Odds ratios (OR) and 95 % confidence intervals (CI) for factors associated 
with poor blood pressure (BP) control (160/90 mmHg or more). 
 
 
Factor 
 
n 
Poor control 
 of BP (%) 
OR 
 (95 % CI) 
Adjusted ORa 
 (95 % CI) 
Gender     
  male 199 64 1.02 (0.69, 1.52) 1.09 (0.72, 1.66) 
  female 229 63 1.00 1.00 
Age (years)     
  < 50 88 59 0.63 (0.36, 1.10) 0.63 (0.33, 1.21) 
  50 – 64 202 61 0.70 (0.44, 1.10) 0.68 (0.41, 1.14) 
  65 – 75 138 70 1.00 1.00 
Education     
  primary 201 65 1.00 1.00 
  secondary 184 62 0.87 (0.57, 1.32) 0.85 (0.54, 1.33) 
  academic 43 63 0.90 (0.46, 1.79) 0.81 (0.39, 1.69) 
Number of 
antihypertensive drugs  
    
  1  196 57 1.00 1.00 
  2  178 68 1.63 (1.06, 2.48) 1.66 (1.06, 2.58) 
  3 - 5  54 74 2.19 (1.12, 4.28) 1.73 (0.84, 3.57) 
Years in treatment     
  < 5 93 61 1.00 1.00 
  5 – 9 104 55 0.77 (0.43, 1.35) 0.65 (0.36, 1.18) 
  10 – 19 120 70 1.47 (0.83, 2.61) 1.03 (0.56, 1.90) 
  > 20 111 67 1.26 (0.71, 2.24) 0.81 (0.41, 1.57) 
Number of problems     
  0 137 57 1.00 1.00 
  1 112 60 1.13 (0.68, 1.87) 1.12 (0.67, 1.90) 
  2 96 69 1.66 (0.96, 2.88) 1.51 (0.85, 2.68) 
  3 + 83 73 2.10 (1.16, 3.80) 1.87 (0.99, 3.53) 
Modification      
  Yes 109 73 1.82 (1.13, 2.95) 1.69 (1.01, 2.84) 
  No 319 60 1.00 1.00 
Number of problemsb     
  0 137 57 1.00 1.00 
  1 112 60 1.13 (0.68, 1.87) 1.18 (0.70, 1.99) 
  2 96 69 1.66 (0.96, 2.88) 1.64 (0.93, 2.90) 
  3 + 83 73 2.10 (1.16, 3.80) 2.12 (1.14, 3.96) 
Modificationc     
  Yes 109 73 1.82 (1.13, 2.95) 1.89 (1.14, 3.13) 
  No 319 60 1.00 1.00 
a adjusted for all other variables in the table 
b adjusted for all except for modification  
c adjusted for all except for number of problems 
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Results from the primary health care based study  
   Eighty percent of men and 79% of women had poor blood pressure control (140/90 
mm Hg or more). The proportion of patients who had poor blood pressure control 
increased from 73% to 85% along with increasing age from the age group of less than 
55 years to the age group of over 74 years (Table 11). In the youngest age group, 57% 
had a systolic blood pressure of 140 mm Hg or more, while the respective figure in the 
oldest age group was 84%. In contrast, the results for diastolic blood pressure showed 
that 59% in the youngest age group and 26% in the oldest age group had a diastolic 
blood pressure of 90 mm Hg or more. Furthermore, poor blood pressure control was 
more prevalent in the patients on monotherapy (82%) than in those on combination 
therapy (78%). 
   High levels of hopelessness towards hypertension (9% of the study population) and 
high levels of perceived tension related to the blood pressure measurement (16% of the 
study population) were associated with poor control of blood pressure (Table 11). The 
difference in blood pressure between the patients with high and low levels of tension 
was 7.3/2.7 mmHg. The medium levels of frustration with treatment were also 
significantly associated with poor control of blood pressure. Those with a high level of 
frustration also had a poorer control of blood pressure than those with a low level of 
frustration, although the difference was not statistically significant.  
   The logistic regression model included one interaction, i.e. that between gender and 
compliance. Non-compliant men had the poorest blood pressure control (88%) 
compared to any other gender x compliance combination. Non-compliance compared to 
compliance in women, however, was significantly associated with better control of 
blood pressure. To illustrate this finding, the Tables 12 and 13 present the mean systolic 
and diastolic blood pressures for compliant and non-compliant men and women in the 
different age groups. Among women aged less than 55 years, both diastolic and systolic 
blood pressures were higher in the non-compliant group. In the age group of 55-64 
years, this difference was only seen in diastolic blood pressure, and in the age group of 
65-74 years, blood pressures were almost the same regardless of compliance. In the age 
group of more than 74 years, diastolic blood pressures were almost the same regardless 
of compliance, but systolic blood pressure was higher among compliant women. It 
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hence seems that our surprising finding is explained by the systolic blood pressure 
values of women aged more than 74 years. 
 Table 11. Odds ratios (OR) and 95 % confidence intervals (CI) for factors associated with poor blood pressure (BP) control (140/90 mmHg or more) in antihypertensive care. 
Variables and interaction 
Study groupa 
 
Reference group 
 
n 
Study groupa 
Poor control of BP (%)
 
n 
Reference group 
Poor control of BP (%)
Adjusted ORb 
 (95 % CI) 
Age       
  55 – 64 years vs. < 55 years 404 76 324 73      1.18 (0.84, 1.67) 
  65 –74 years vs. < 55 years 515 84 324 73      2.11 (1.47, 3.02)* 
  > 75 years vs. < 55 years 288 85 324 73      2.28 (1.48, 3.50)* 
Number of antihypertensive agents      
  2 vs. 1 488 77 613 82      0.60 (0.44, 0.81)* 
  3-5 vs. 1 430 80 613 82      0.71 (0.50, 0.99)* 
Duration of hypertension        
  5-9 years vs. < 5 years 318 75 392 77      0.94 (0.66, 1.35) 
  > 10 years vs. < 5 years 821 83 392 77      1.35 (0.98, 1.86) 
Hopeless attitude towards hypertension      
  medium vs. low 370 81 1026 78      1.09 (0.80, 1.49) 
  high vs. low 135 89 1026 78      2.16 (1.20, 3.88)* 
Perceived tension with blood pressure measurement      
  medium vs. low 163 82 1128 78      1.13 (0.73, 1.74) 
  high vs. low 240 84 1128 78      1.60 (1.08, 2.36)* 
Frustration with treatment        
  medium vs. low 276 84 1163 78      1.50 (1.04, 2.18)* 
  high vs. low 92 86 1163 78      1.83 (0.98, 3.44) 
Gender x compliance (self-reported)      
  men, compliance vs. women, compliance 522 79 800 80      1.06 (0.80, 1.42) 
  men, non-compliance vs. women, non-compliance 85 88 124 73      3.78 (1.70, 8.39)* 
  women, non-compliance vs. women, compliance 124 73 800 80      0.60 (0.38, 0.95)* 
  men, non-compliance vs. men, compliance 85 88 522 79      2.14 (1.05, 4.36)* 
  men, non-compliance vs. women, compliance 85 88 800 80      2.28 (1.13, 4.61)* 
  women, non-compliance vs. men, compliance 124 73 522 79      0.57 (0.31, 1.03) 
a by study group, we mean the group of patients compared with the reference group, b adjusted for all other variables in the table, * statistically significant 
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 Table 12. Mean (+SD) systolic blood pressures according to age, gender and compliance. 
 
 < 55 yrs. 55-64 yrs. 65-74 yrs. > 75 yrs. Total 
Mean +SD systolic blood pressures for compliant patients (n) 
 Men 143.3 + 16.0 (118) 149.4 + 19.6 (150) 154.6 + 19.2 (195) 160.3 + 22.1 (62) 151.3 + 19.7 (525) 
 Women 143.5 + 16.6 (157) 149.6 + 17.0 (187) 157.4 + 20.0 (265) 160.4 + 20.5 (203) 153.7 + 19.9 (812) 
Mean +SD systolic blood pressures for non-compliant patients (n) 
 Men 146.8 + 18.7 (25) 156.5 + 18.9 (33) 157.8 + 16.3 (20) 162.4 + 19.8 (9) 154.6 + 18.8 (87) 
 Women 150.4 + 17.5 (27) 149.3 + 20.7 (37) 156.8 + 20.9 (39) 155.1 + 27.0 (21) 152.9 + 21.3 (124) 
 
 
 
Table 13. Mean (+SD) diastolic blood pressures according to age, gender and compliance. 
 
 < 55 yrs. 55-64 yrs. 65-74 yrs. > 75 yrs. Total 
Mean +SD diastolic blood pressures for compliant patients (n) 
 Men 92.8 + 9.4 (118) 89.8 + 9.8 (150) 87.3 + 9.0 (195) 84.5 + 11.4 (62) 88.9 + 10.0 (525) 
 Women 90.2 + 7.7 (157) 88.6 + 8.8 (187) 87.3 + 9.5 (265) 82.2 + 10.5 (203) 86.9 + 9.7 (812) 
Mean +SD diastolic blood pressures for non-compliant patients (n) 
 Men 94.8 + 8.9 (25) 95.9 + 14.8 (33) 93.0 + 9.8 (20) 91.4 + 6.1 (9) 94.5 + 11.4 (87) 
 Women 94.1 + 10.1 (27) 90.5 + 9.4 (37) 87.1 + 10.1 (39) 82.5 + 9.9 (21) 88.9 + 10.4 (124) 
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5.4 Model for classifying and understanding non-compliance 
 
   The literature review showed non-compliance to be a big problem, and new insights in 
this area have been scarce for a long time. The following chapter presents an attempt to 
approach the complexity of the compliance phenomenon in a novel way, by looking 
first at different non-compliant behaviours and then at the different reasons for these 
behaviours.  
   Non-compliant behaviours may appear at different stages of the medicine-taking 
process (Figure 2). When compliance is considered in a wider context than just regular 
medicine-taking, the words ‘use’, ‘medicines’ and ‘medication’ can be replaced by the 
words ‘follow’, ‘instructions’ and ‘treatment’. Non-compliant behaviour is probably 
more prevalent at some stages than others, but it is necessary to try to outline the overall 
process of medicine-taking. By studying medicine-taking in the context of the figure 
shown below, it is possible to get information about the extent of non-compliant 
behaviour at the different stages of the medication-taking process. In current compliance 
research, the focus is mainly on stage 5 (occasionally also on stage 4 and 6). However, 
the different non-compliant behaviours in figure 2 are merely consequences and do not 
show us any reasons for this behaviour. 
 
Classificatory model of  non-compliance and non-concordance  
   Non-compliance should be seen as a symptom of something, and there may be several 
reasons for it, even though the consequences appear to resemble each other. In the 
literature, compliance has often been approached as a single entity. To achieve progress 
in compliance research, it is obviously necessary to create a theoretical model that 
differentiates between the many forms of non-compliance. The division of non-
compliance into intentional and non-intentional types represents only the first phase in 
the process of classifying non-compliance in meaningful classes (Figure 3). These two 
major classes need to be further subdivided. Intentional non-compliance may relate to 
individualistic ways of taking care of one’s health, intelligent choices and ethical/moral 
or religious values. These three sectors in the model are indicated with a dotted line, 
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because they do not belong to the model that focuses on concordance instead of 
compliance. Different priorities of life may represent intentional non-compliance.  
   Non-intentional non-compliance may be divided into patient-related and system-
related factors. Patient-related factors include forgetfulness, lack of attention and 
disease- related reasons. System-related factors include misunderstanding, lack of 
information and problems in the supply or use of medicines.  
   Different types of non-compliance require different approaches at both the patient and 
the system level. No single solution will alone solve the problem of non-compliance. 
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Figure 2. Non-compliant behaviours in the medicine taking process. 
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Figure 3. Classificatory model of  non-compliance and non-concordance. The three categories with dotted line do not belong to the model 
with the focus on concordance. The dotted line from priorities to forgetfulness represents secondary memory problems. 
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 6   DISCUSSION 
6.1 Study populations 
 
Pharmacy-based study population 
   Our pharmacy-based study population has some limitations. It consisted of patients 
visiting nine pharmacies in two cities in Finland personally. Our study design did not 
involve any possibility to remind non-participants. It is possible that, through more 
active motivation by the pharmacy personnel, a higher proportion of the patients had 
returned the questionnaire. The response rate to the questionnaire was moderate, and it 
is possible that the properties of the non-participants differed from those of the 
participants (e.g. in the area of non-compliance) causing selection bias in the study 
population. Despite the eventual limitations on representativeness, the study offers 
interesting possibilities for clarifying the treatment problems of hypertensive patients. 
 
Primary health care based study population 
   Our primary health care based study population also has limitations. The thirty health 
centres were randomly selected by stratified sampling as representative of the basic 
population in terms of size and geographical location. Twenty-six of these health 
centres agreed to participate, and the patients’ response rate was 80%, leading to a high 
number of study participants. This study population hence represents quite well the 
hypertensive patients in Finnish primary care. The health examination, and the 
possibility to receive information of its results in the familiar health centre environment 
may have contributed to the better participation compared to the pharmacy-based study. 
Although this study has many strengths, it is limited to the patients who visited the 
health centres and thus excludes treatment drop-outs. 
 
 
6.2 Study design 
 
   Both in the pharmacy and the primary health care based studies, the study design was 
a cross-sectional survey. This limits the applicability of the results to prevalences and 
 associations between different variables and gives an opportunity to formulate 
hypotheses. The causes and consequences between variables cannot be explained in 
cross-sectional studies. Prospective studies are needed to confirm the hypotheses that 
are formulated in cross-sectional studies. 
 
 
6.3 Questionnaires 
 
   There is lack of validated questionnaire focusing on compliance and treatment 
problems in hypertension care. Our questionnaire requires further development and 
validation. We identified different areas of patient-perceived problems and attitudes and 
their associations with non-compliance and poor outcome of hypertension treatment. 
This can be used as a basis for developing a validated hypertension-specific 
questionnaire. A questionnaire about general health, e.g. SF-36 (Ware and Sherbourne 
1992), combined with a hypertension-specific questionnaire could offer tools for 
clinical practitioners to better understand the different problems of hypertensive 
patients. 
 
 
6.4 Variable definitions 
 
Patient-perceived problems 
   The prevalence of patient-perceived problems in the primary health care study was 
based on one positive answer to the original questions.  This procedure may have led to 
false positives findings in some cases. 
 
Compliance 
   In the pharmacy-based study, compliance was assessed by asking whether the patient 
had ever tried to manage with less antihypertensive drugs than that prescribed. In the 
primary health care study, compliance was a combination of whether the patients 
admitted having taken their antihypertensive medication less often than prescribed by 
 the doctor during the last year and the ”modification of dosage instructions”, summing 
up four questions, which were originally based on factor analysis followed by 
processing with reliability and internal validity analyses.  
   In compliance research, it is important to establish what is being measured and how it 
can be measured reliably. Non-compliance may appear in different stages of the 
medication-taking process, and it may be due to several reasons requiring different 
approaches to measurement. 
   The questions in the pharmacy-based study (have you ever tried to manage with less 
antihypertensive drugs than prescribed) concentrated on intentional compliance as one 
entity without defining the time period in question. There is a need to differentiate 
between current and past behaviours. This bias may be of less importance due to the 
patients’ possible memory problems. 
   The first compliance question in the primary health care based study (Have you taken 
antihypertensive medication less often than prescribed during the past year?) also has 
limitations. It has a strong tone of intentional non-compliance, but there is also a 
possibility to interpret this to mean non-intentional non-compliance. 
   The sum variable brings us back to the problem of time. The first question (I have also 
tried to save money by diminishing the use of antihypertensive medication.) measures 
clearly intentional non-compliance related to the priorities of life with no mention about 
the time period. The second question (The pharmacy staff have paid attention to the fact 
that I don’t use my antihypertensive medication exactly as prescribed) do not specify 
the kind of non-compliance inquired in these questions or the time period. The third 
question (I haven’t taken my antihypertensive medication recently, and they haven’t 
paid any attention to it in the health centre.) implies something about the assumed time 
period. Furthermore, it concentrates clearly on intentional non-compliance, but does not 
specify it more precisely. The fourth question (They have paid attention to my irregular 
use of antihypertensive medication in the health centre.) do not specify the kind of non-
compliance inquired in these questions or the assumed time period. Thus, the 
combination variable of these questions represents mainly intentional compliance.  
   In these studies, the prevalences of non-compliance based on self-report by the 
patients were not high. However, the non-compliance prevalences based on self-report 
 must be regarded as conservative estimates of the true level of non-compliance (Morris 
and Schulz 1992, Rudd 1995). 
   All the compliance questions discussed above, however, clearly approach compliance 
in the area of antihypertensive medication-taking. Furthermore, despite their limitations, 
self-report measures represent the average quality of current compliance research and 
thus offer interesting possibilities for research.  
 
Blood pressure 
   In the pharmacy-based study, it was not possible to determine how many patients 
really had a personal blood pressure card and how many actually based their answers on 
memory. However, according to the results of a study where patients checked and 
reported their blood pressures, it seems that the patient is a reliable source of blood 
pressure readings, at least when memory problems do not confuse the results (Cheng et 
al 2002). Thus, possible memory problems may have caused inaccuracy in the blood 
pressure readings. In the pharmacy-based study, the limit for poor blood pressure was 
older (160/90 mmHg or more), i.e. higher for systolic blood pressure than in the primary 
health care based study (140/90 mmHg or more). This may have also effect on the 
results of this study.  
   In the primary health care based study, the accuracy of blood pressure measurements 
depends on the trained health nurses measuring the blood pressure. The different skills 
of each nurse can cause variability in the blood pressure readings. Furthermore, the 
inaccuracy of the device, the circumstances of measurement, the lack of rest before 
measurement and many other factors may cause errors the blood pressure measurement 
(Beevers et al. 2001a).   
 
 
6.5 Discussion of the results 
6.5.1 Perceived problems and attitudes 
 
   In both of our study populations the majority of patients reported perceived problems 
and negative attitudes in the treatment of hypertension. In fact, when an adequate 
 number of questions were asked, practically every hypertensive patient seemed to have 
experienced these problems. Furthermore, our finding about five problems per patient 
also indicates the large prevalence of these problems, and it seems obvious that the 
treatment of hypertension is today far from optimal. 
 
Perceived problems related to the health care system and personnel 
   This study showed that nine out of 10 hypertensive patients had perceived health care 
system related problems. The high prevalence of lack of follow-up by the health centre 
shows one major aspect of antihypertensive treatment that requires more attention. The 
majority of these patients reported that their visits to a nurse or a doctor because of 
hypertension had remained under their own discretion. Thus, our present system of 
health care needs to be improved by involving all hypertensive patients in regular 
follow-up. There should be a functional system of reminders in appointment-making or 
control visits for possible drop-outs. 
   More than half of the patients wanted more information. Appropriate information and 
reinforcement could prevent many other problems in the treatment of hypertension, but 
we lack a clear agreement on the responsibilities between the different professional 
groups in health care. Watkins et al (1987) reported that an information booklet about 
hypertension, which was mailed to the patients, was continued to be in regular use by 
one-fifth of the patients after a year. Howard et al (1999) reported that over three-
quarters of the patients ranked 15 of the 22 information items about medicines as 
important in the interview. However, when information is provided to hypertensive 
patients, the quality of information is very important. A recent study in the UK showed 
major deficiencies in the patient information leaflets meant for hypertensive patients 
(Fitzmaurice and Adams 2000). In two-thirds of the leaflets, hypertension was not 
explained in the context of the overall cardiovascular risk. The importance of continued 
monitoring was not explained in over half of the leaflets. Furthermore, a third of the 
leaflets did not state that the treatment is long-term. However, good information alone is 
not enough. We need to ensure that the patient has absorbed the new information and to 
educate health care professionals to know how to do that. 
    Lack of support by health care personnel suggests that many hypertensive patients are 
rejected and alone with their hypertension treatment. This indicates a need to educate 
both health care personnel and family members. In a study where family members were 
educated to support the patient, hypertensive patients showed higher levels of 
appointment-keeping behaviour and weight and blood pressure control than the ordinary 
care group (Morisky et al 1985). It has also been shown that measures of social network 
did not predict the incidence of hypertension, but did predict the 15-year mortality 
hazard (Vogt et al 1992). 
   Every fifth of our patients had problems with the practical aspects of hypertension 
care and the scheduling of blood pressure measurements. These problems were most 
common in the age group of under 55 years. This raises the question of how the health 
care system could offer suitable services for all hypertensive patients as well as for other 
patients with chronic disease, especially for the working-aged population. Self-
monitoring of blood pressure may be an option for some patients, but that will not 
eliminate the need to provide more flexible hypertension services for the patients. In 
Finland, it has been possible to decrease out-of-hours consultations by adopting a 
system where general practitioners have a list of defined patients (Vehviläinen and 
Takala 1996). 
   It has been suggested that the costs of antihypertensive treatment may be an obstacle 
to blood pressure control in certain subgroups of the population (Shulman et al 1986). 
Keeler et al (1985) found that hypertensive patients with free care had lower blood 
pressures than cost-sharing patients. In Finland, it has been shown that reimbursement 
status (special or normal) is not associated with non-compliance (Wallenius et al 1995). 
Every tenth patient reported a lack of special reimbursement for antihypertensive 
medication. This should naturally be taken care of when the patient is entitled to the 
special reimbursement. 
 
Patient-related problems 
      This study showed that nine out of 10 hypertensive patients had perceived patient-
related problems. The problem of denial is well-known in various chronic diseases 
(Goldbeck 1997). In our study, two-thirds had difficulties to accept being hypertensive. 
 The prevalence of denial was highest in the younger age groups. It is a great challenge 
to the health care system to guide and help the patient to endure and accept being 
hypertensive. This problem is not only an attitude problem, but also an information 
problem. 
   The high prevalence of careless attitude towards hypertension, especially among older 
women, may reflect the fact that hypertension is very common and asymptomatic. This 
may cause hypertension to be considered as a harmless disease. It also points to the 
need for improvements in informing patients about the risks of hypertension. 
   As every third of the patients experienced hopelessness towards hypertension and did 
not believe that their hypertension could be controlled, the health care in our country 
has obviously failed to convince the patients about its potentials. This may be caused by 
problems both in information sharing and in using effective medications in the 
treatment of hypertension. 
   Frustration with hypertension treatment was most common among the youngest 
patients. It was partly due to ineffective treatment, frequent visits to the health centre 
and too many changes required in living habits. These problems might be associated 
both with a lack of information and with ineffectiveness of the health care system. 
   Every fourth patient felt tension about blood pressure measurement. This is probably 
related to such well-known phenomena of blood pressure measurement as the white-
coat effect and white-coat hypertension (Sandvik and Steine 1998, Martinez et al 1999). 
However, the association between subjective feelings and objective measurements 
remains unexplained because of the study design. These subjective feelings may also be 
associated with patient characteristics and the way certain patients react in different 
exciting situations. 
   ”Perceived economic problems” were included among the patient-related problems. 
This variable may include patients who have real economic problems in treating their 
hypertension. In Finland, however, social services are quite good, and the patients who 
cannot afford to buy their medication are provided them free of charge. Twenty-five 
percent of the patients reported having economic problems. At the same time, however, 
90% of the patients were living on a pension, salary or enterpreneurial income. 
Therefore, we assumed that this question is actually related to the economic priorities in 
 the person’s life. However, there are probably some patients who have a really difficult 
economical situation. 
 
Difficulties to be a hypertensive patient and interference with daily life 
   As many as every third thought that it is difficult to be a patient with hypertension, 
compared with every sixth patient in an earlier study in Finland (Wallenius et al 1995). 
This question cannot differentiate the difficulties caused by the diagnosis of 
hypertension itself from the problems related to the treatment of hypertension. When the 
pre-visit estimate of the time needed was higher than the post-visit estimate of the time 
spent with the physician, the patients were less satisfied (Lin et al 2001). Patients with 
unvoiced desires during office visits have been reported to be less satisfied with the care 
received and to have least symptom improvement (Bell et al 2001). Obviously, a lack of 
information, a lack of support by health care personnel and a need for a flexibly and 
properly functioning health care system contribute to this negative patient role. 
   Many patients reported that they had been obliged to give up pleasant activities due to 
hypertension, or that hypertension or drug usage had interfered with their daily routines 
and hobbies. In these situations, health care professional should emphasize the benefits 
of treatment to the patient, try to support the patient and consider whether there are 
treatment choices that could alleviate the patient’s life. 
 
Memory problems 
   Every sixth patient reported memory problems in taking antihypertensive medication. 
This problem is important to consider in the medical treatment of every chronic disease. 
The reason may be just normal forgetting or dementia, which should also be treated, or 
if the patient is no longer capable of taking care of his/her medication, adequate help 
should be provided. However, medical practitioners should not underestimate the 
importance of discussing with the patient about tailoring the medication as a part of 
everyday life as well as using different memory aids, e.g. pill boxes. 
 Adverse effects and symptoms 
   In the primary care based study population the prevalence of adverse effects of 
hypertension treatment on sexual function was higher for men than for women. Studies 
including only men have also revealed high prevalence of sexual problems among 
hypertensive patients (Croog et al 1988, Chang et al 1991). It may, however, be difficult 
to determine whether or not hypertensive treatment is the reason for such problems. In 
the pharmacy-based study population, symptoms of high blood pressure and adverse 
drug effects were common. The patient may also have other diseases and medications 
for these diseases and different living habits which may give rise to things that the 
patient considers to be due to hypertension or its treatment. It has been shown that 
especially the patients who experienced symptoms of high blood pressure and adverse 
drug reactions need more information about adverse effects than others (Enlund et al 
1991). This sets to us the challenge of offering customized information to those patients 
who have negative experiences related to hypertension and its treatment. 
 
 
6.5.2 Factors associated with non-compliance 
 
   This study showed that hypertensive patients had a high number of patient-perceived 
problems many of which were associated with a risk of intentional non-compliance with 
antihypertensive medication. The association between perceived problems and non-
compliance was shown in the areas of everyday life related problems, health care 
system related problems and patient-related problems. According to these results, it 
seems obvious that successful treatment of hypertension must take into account the 
patient’s perceptions and views about the treatment of hypertension and be modified 
accordingly.   
   The patients with a high number of everyday life related problems were almost four 
times more likely to be intentionally non-compliant than those without such problems. 
Our results support the earlier findings of Wallenius et al (1995) about the association 
of intentional non-compliance with patient-perceived problems. The patients who have 
struggled with adverse effects, memory problems and problems in hobbies due to 
 hypertension or its treatment may need a customized approach from a health care 
professional. The possible problems in work and personal relationship should also be 
taken into consideration. In medical practice, it may be easy to pass seemingly trivial 
complaints of the patient. However, these complaints may be a small indicator of larger 
treatment problems experienced by the patient. It is possible that these problems trigger 
non-compliance or even dropping out of treatment. To prevent the consequences of 
these problems, we should ask our patients about possible problems in treatment. 
    In the primary health care based study patients experiencing high levels of health care 
system related problems were almost four times more likely to be non-compliant. 
Furthermore, the patients with a high level of patient-related problems were over two 
times more likely to be non-compliant. The detected interaction between education and 
the number of antihypertensive drugs needs to be confirmed in other studies. Those with 
higher education and two antihypertensive drugs had better compliance than those with 
higher education and monotherapy or those with lower education and two 
antihypertensive drugs. 
   The association between health care system related problems and non-compliance 
shows the importance of continuous quality improvement of the structures and 
processes of care. It was shown more than 20 years ago that, by reorganizing treatment, 
it is possible to reduce the number of drop-outs from treatment (Takala et al 1979). The 
special challenge is to maintain the improvements reached in long-term treatment.  
Information about hypertension and its treatment is an important way to increase 
patients’ motivation and understanding. In Czecho-Slovakian population, 52% of the 
patients who were aware that increased blood pressure reduces life expectancy used the 
prescribed drug regularly compared with only 9% of those without that knowledge 
(Balazovjech and Hnilica 1993). Decreased overall satisfaction with care and 
dissatisfaction with the interpersonal manner of the doctor have also been associated 
with lower compliance with medication (Harris et al 1995). 
   Hypertensive patients have different attitudes, characteristics and thoughts related to 
hypertension and its treatment. These personal features may help us to identify different 
patient types. A study including hypertensive patients, mainly on non-pharmacological 
treatment, reported careless, serious, adjusted and frustrated attitudes towards 
 hypertension and its treatment (Lahdenperä and Kyngäs 2001). We formulated the 
patient-related problem variable by combining six possibly problematic attitudes and 
characteristics. In our study, self-reported noncompliance was associated with problems 
of this kind, including carelessness and frustration. A high level of hostility in the 
patient has previously been reported to be associated with skipping antihypertensive 
medication doses (Lee et al 1992). In medical practice, it would be important to 
recognize the different types of patients and to be able to suggest to each of them a 
suitable mode of antihypertensive treatment. Attitudes are not unchangeable, and 
problematic attitudes that are modifiable are therefore a challenge to the health care 
system. Thus it would be possible to help our patients to achieve the goals of treatment 
and to improve economical allocation of health care resources.   
   We also found an association between intentional non-compliance and the experience 
of adverse drug effects, which supports the earlier findings (Shaw et al 1995, Wallenius 
et al 1995). 
 
 
6.5.3 Factors associated with poor control of blood pressure  
 
   According to our results only a minority of hypertensive patients had their blood 
pressure controlled. The situation would have been even worse in the pharmacy-based 
study population, if the limit for poor blood pressure had been as strict as with the 
primary health care based study population. We showed that patient-perceived everyday 
life related problems, hopeless attitude towards hypertension and frustration with 
treatment were associated with poor outcomes of antihypertensive drug therapy. Our 
results suggest that health care professionals are dealing daily with a large number of 
patients with these problems. These patients also have poor blood pressure control and 
thus deserve clearly more attention both in everyday medical practice and in 
cardiovascular research. 
   While the patient-perceived every day life problems were associated with non-
compliance in the pharmacy-based study, the association with blood pressure control 
depended on the logistic regression model used.  
    We identified the hopeless patients by using a simple two-item tool and the frustrated 
patients with a three-item tool in the primary health care based study. High level of 
hopelessness towards hypertension treatment is associated with poorer control of blood 
pressure. Similarly, persons who experienced frustration with their treatment had a 
poorer control of their blood pressure. It is interesting to compare our hypertension-
specific hopelessness findings with those reported by Everson et al (2000), who showed 
that normotensive middle-aged men with high levels of general hopelessness at baseline 
were more likely to develop hypertension 4 years later. Earlier, they also showed high 
and moderate levels of general hopelessness to be associated with an increased risk of 
all-cause mortality (Everson et al 1996). 
   One important question is whether hopelessness and frustration with treatment are 
causes or consequences of poor blood pressure control. We suggest that they may be 
both a cause and a consequence. It is possible that if a fully compliant patient has tried 
several antihypertensive medications with poor results, s/he becomes frustrated or 
develops an attitude of hopelessness towards the treatment. Therefore, it is very 
important to listen to patients and to recognize all individual treatment problems. It is 
also important to discuss the health benefits of the treatment. Referral to a hypertension 
specialist may be needed in some cases. Quite good results have been reported even 
from the treatment of resistant hypertension: blood pressure remained under control in 
53% of the patients and improved in 11% of the patients (Yakovlevitch and Black 
1991). 
   On the other hand, hopelessness or frustration may also be a cause for poor blood 
pressure control. If the patient does not believe that his/her hypertension can be 
controlled, this lack of belief may affect his/her overall treatment behaviour. None of 
the perceived health care system related problems were found to be associated with poor 
blood pressure control. Is that really true, or are there limitations in patients` evaluation 
of the health care system? Actually, a patient’s hopelessness and frustration might 
derive from problems in the health care system. In the area of information sharing, we 
have certainly room for improvement: the health care personnel could provide 
motivating information and support.  
    Tension at blood pressure measurement was associated with poor blood pressure 
control. This is probably related to the well-known problems of blood pressure 
measurements, such as the white-coat effect and white-coat hypertension (Sandvik and 
Steine 1998, Martinez et al 1999, O’Rorke and Richardson 2001). In this connection, it 
should be taken into account that the white-coat effect has also been found, 
contradictorily, to decrease blood pressure in a small group of patients (Kumpusalo et al 
2002). The study design did not allow us to clarify whether there is any association 
between the perceived tension about blood pressure measurement and objective 
measurements. Furthermore, it is possible that these subjective feelings are associated 
with the characteristics of the patient and the way they react in different exciting 
situations. 
   Non-compliance has been associated with poor blood pressure control (Mallion et al 
1998). This was also seen in our study in men, but the situation was otherwise slightly 
confusing, especially among elderly women. More precise understanding of this 
phenomenon would require data e.g. on baseline blood pressure, follow-up 
measurements and appropriateness of antihypertensive medication and more precise 
information on compliance and its variability over time. It has been suggested that 
compliance decreases between clinic visits (Cramer et al 1990). This phenomenon may 
be partly explained by ”white-coat compliance”. Are older women trying to hide their 
non-compliant behaviour more than others by for instance, taking extra tablets before 
scheduled blood pressure measurements or is there an over-medicated non-compliant 
population among older women? Their willingness to admit non-compliance may also 
differ from that of other non-compliant patients.  
 
 
6.5.4 Compliance model 
 
   Several theoretical models have been used to explain non-compliance, but with quite 
poor success (Barber 2002). This may be partly related to the fact that the theories have 
been applied to all non-compliant patients, regardless of whether their non-compliance 
is intentional or non-intentional (Barber 2002). A patient showing intentional non-
 compliance knows how s/he should act, but has made a conscious decision about his/her 
way of acting and thus deviates intentionally from the doctor’s advice, while patients 
showing non-intentional non-compliance would like to follow the doctor’s advice, but 
are for some reason unable to do so (Cochrane et al. 1999, Barber 2002).  
   The classificatory model of non-compliance and non-concordance was created from 
the perspective of medication-taking, but this model can also be applied to non-medical 
treatments. The model takes into account both compliance and concordance. According 
to Jonsen (1979) in “the ethics of medical care, it should be remembered, rest on 
ambiguous and not always compatible imperatives; the physician’s responsibility to 
care derives from the patient’s request for care and, on the other hand, derives from the 
patient’s need for help, even when not explicitly requested.” In concordance, there is no 
private entrepreneur with an individualistic way or an intelligent choice, because these 
aspects have been negotiated and the physician may have re-evaluated the treatment 
accordingly.  
   The term ‘compliance’ presumes a situation where the physician gives paternalistic 
orders about the treatment to a patient according to his or her own values. In 
concordance, contrawise, the physician and the patient negotiate the principles of 
treatment and the patient’s thoughts and values are listened to and respected. The word 
‘compliance’ is used here more because it has a longer history and it is a more familiar 
term for many health care professionals, but after all, concordance is what compliance 
should be. 
   In the model it is essential to identify the central problem of the patient’s non-
compliance or non-concordance. The physician may sometimes think that s/he has 
understood the patient’s view, although the patient feels differently (Jenkins et al 2003). 
It is obvious that such problems may lead to misclassification of patient behaviour.  
 
Non-intentional non-compliance and non-concordance 
   First, forgetfulness has been reported as a reason for non-compliance (Cooper et al. 
1982, Balazovjech and Hnilica 1993, Dusing et al. 1998) and everybody is likely to 
forget occasionally. Tailoring medication as part of everyday life and using memory 
aids may be helpful for many patients in different situations e.g. elderly patients and 
 persons with busy work schedules. It is good to realize that the reason for forgetting 
may also be a disease, e.g. dementia. However, forgetting to take drugs may be 
experienced as a more socially acceptable reason than intentional behaviour, and the 
reliability of these responses should be considered with caution. Some patients may 
think that they are compliant, even when they are not, and this is related to the fact that 
they have not been given adequate instructions concerning their treatment (Kyngäs et al. 
2000). Misunderstandings may also lead to non-compliance (Cooper et al. 1982). It is 
obvious that these patients need thorough information about their disease and its 
treatment. In addition to forgetfulness and misunderstandings, it is possible to 
differentiate a lack of attention, which may also lead the patient to taking wrong 
medicines or doses. These patients may benefit from dosing aids and instructions that 
promote attention. 
   If the patient is no longer capable of taking care of his/her medication because of a 
disease, s/he will need help and treatment for his/her disease. Dementia is one example 
of a disease possibly underlying non-intentional non-compliance and non-concordance. 
Some psychiatric disorders may also belong to this group. Not surprisingly, depression 
has been found to be associated with non-compliance (DiMatteo et al. 2000, Wang et al. 
2002). About every fourth or fifth citizen in Finland has a mental health disorder, and 
only one fifth of them have sufficient psychiatric treatment, while over half have no 
treatment at all (Joukamaa and Veijola 2002). Therefore it should be asked how much 
the high prevalence of mental health disorders affects the treatment of other diseases. 
However, there are probably some cases where it is difficult to differentiate between a 
psychiatric disorder and the priorities of life problems. 
   Some patients have attributed their non-compliance to their inability to afford to buy 
medicine (Cooper et al. 1982). It has also been found that, when cardiovascular drugs 
were offered free of charge to indigent patients, their drug compliance improved and the 
number of hospitalizations decreased (Schoen et al 2001). A study about Medicare 
beneficiaries showed that the patients who had a gap in their drug coverage used less 
prescribed medications and had difficulties in paying for their medications compared to 
the patients without problems with their drug coverage (Tseng et al 2004). Furthermore, 
transportation problems in getting medications or incompetence of the health care 
 system to supply the necessary medicines may lead to non-intentional non-compliance 
and non-concordance. These problems show that there is a need to improve the 
structures of health care and social services. Such reasons should be rare in Finland and 
the countries where the health care, social service system and the structures of society in 
practice organize supply of medicines to all residents in need of medication. Especially 
in these societies, the question may often be related to economic priorities rather than 
real economic shortage.  
   Unreasonable adverse effects in the use of medication may lead to non-intentional 
non-compliance and the physician should consider re-evaluation of treatment in these 
cases. This does not, however, apply to the situations where the disease or its treatment 
causes reasonable difficulties e.g. symptoms or adverse drug effects which make the 
patient intentionally non-compliant and non-concordant. Some patients have reported 
weighing up the side effects of their antihypertensive medication with the benefits and 
having decided the medication to be worth of it (Benson and Britten 2003). 
   When some practical problems (e.g. with medication bottles or prescription refills) are 
really unreasonable the problem can be classified as causing non-intentional behaviour, 
and it is obvious that there is a need for more user-friendly packages and practices in 
these cases. Furthermore, inappropriate or ineffective prescribing practices may cause 
extra difficulties to the patient and thus unnecessarily undermine the patient’s position.  
 
Individualistic ways of taking care of health and intelligent choice 
   Some patients try intentionally to deviate from the doctor’s instructions in order to 
maximize their health by titrating the dosage according to the situation: giving such 
reasons as adverse effects, too big or too small doses, feeling well without drugs or 
feeling worse than before medication, being asymptomatic, and feeling that the 
medication is unnecessary (Cooper et al. 1982, Balazovjech and Hnilica 1993, Shaw et 
al. 1995, Dusing et al. 1998, Svensson et al. 2000, Ross et al 2004). The patients who 
discussed their adverse effects with the physician were more likely both to continue 
their therapy and to change their medication than the other patients (Bull et al 2002). 
Patients’ decisions about changing or stopping medication are usually based on rational 
arguments (Svensson et al. 2000). In the study by Benson and Britten (2003) half of the 
 hypertensive patients reported weighing up their concerns and treatment benefits when 
starting their antihypertensive medication. Our study also suggested an association 
between a “hopeless attitude towards hypertension” and intentional non-compliance. It 
is possible that this attitude is related to the lack of information of the strength of 
hereditary factors. Hence, a part of the patients may try to improve their health by being 
non-compliant and non-concordant. 
   Some patients have also reported that they do not like medicines, or that they find 
them as unnatural (Svensson et al. 2000). They may try to maximize their health with 
methods of alternative and natural medicine because of a lack of knowledge. There is 
also a related finding among hypertensive patients that intentional non-compliance is 
associated with the use of home remedies (e.g. garlic) instead of antihypertensive drugs 
(Shaw et al. 1995). Disease-related beliefs and many other cultural and attitudinal 
factors may also be associated with intentional non-compliance (Delgado 2000). Part of 
these patients, however, have not understood the seriousness of hypertension. This is 
illustrated by the following comment by a hypertensive patient: ”It is really quite an 
insignificant illness. Women who are neurotic and men who have stress because of their 
work have hypertension. I also think like that.” (Lahdenperä and Kyngäs 2001).  
   Some non-compliant patients have reported that they do not understand the  
information given by the physician and information leaflets (Gascon et al 2004). They 
also feel that they have been advised to change their lifestyle without any explanation as 
how to do it (Gascon et al 2004). Successful information sharing requires the quality of 
the communication between the patient and the physician to be good. Non-compliant 
patients have reported that the physician is busy, eye contact is rare, and there is no real 
conversation (Gascon et al 2004). 
   It would thus be important for health care professionals to share detailed information 
with hypertensive patients about their disease, so that the patients would understand the 
benefits of treatment before something serious happens. A good example of this could 
be a Swedish patient who really understood the importance of antihypertensive 
medication when his father, who had been hypertensive for years, died of stroke: ”I 
haven’t taken my pills for several years. (No-o) It must have been when I found out that 
the pills prevent damage that I began to take them properly. (Uh-huh)” (Kjellgren et al. 
 1997). Patients have also reported their reason for complying to be a desire to avoid 
complications of hypertension and to keep their blood pressure readings in control 
(Svensson et al. 2000). Some patients may also think that their antihypertensive 
medication has cured the hypertension, because their blood pressure readings are now 
good, and may therefore think the medications as unnecessary. 
   Future research, in the group of individualistic ways patients, may benefit from the 
findings of the health belief model which tries to explain the probability of individuals 
to function in ways promoting their health (Janz and Becker 1984). This is affected by 
the perceived benefits, barriers of treatment and threat of disease. These three areas are 
also modified by demographic and socio-psychological background factors. 
Furthermore, the model is constructed so that it is probably not useful, if a majority of 
individuals do not regard health as having high value, which makes it impracticable in 
priorities of life cases. 
   It is also possible that intentional non-compliance may improve some patients’ health, 
which is called “intelligent” non-compliance. They are likely quite rare. However, the 
concept ‘concordance’ is more suitable to these intelligent choices and the previously 
mentioned individualistic cases. In both groups of intelligent choice and individualistic 
ways, the patient thinks that his/her actions promote his/her health, i.e. the purpose is 
good, but that will only happen in the case of intelligent choice. 
 
Priorities of life 
   In situations involving different priorities of life the central problem is not a lack of 
information. This group may have characters that have taken into consideration years 
ago by Jonsen (1979) who points out that non-compliance may be an indicator of more 
deeper needs than just the need for medication. There is no drug for finding a meaning 
of life or for dealing with the most profound questions of life, but the physician should 
be able to discuss the meaning of life, and why there are so many priorities that conflict 
with the value of health and especially with the value of life, which is the prerequisite 
for all other priorities. 
   A Finnish study on 1037 persons aged 60 years showed that the third most prevalent 
personal problem was the excessive idealization of youth in our society (Vaarama et al 
 1999). The most common problem was disease and deficiency in capacity, while 
financial problems came second. The excessive idealization of youth in our society was 
even more prevalent than social problems, violence and criminality in neighbourhood, 
lack of hobby possibilities and lack of health and social services. On the other hand, the 
shocking ”so what ” attitude can currently be seen even among young people infected 
with HIV (Ranki 2002). Both of these findings may be connected with the time 
distortion in health-related behaviours. For some people health seems to have a high 
priority only in the short term, and excessive idealization of youth and desire to remain 
young may make this trend even worse by leading to an illusion of eternal youth. These 
people may ask: why use medications that prevent death or complications of disease, 
i.e. prevent nothing, if there is no death and old age anymore (or at least the nearly 
eternal youth has moved death so far away that you do not need to think about it before 
it is too late).  
   Non-compliance is also related to an irregular lifestyle or disturbances of everyday 
life (Balazovjech and Hnilica 1993, Dusing et al. 1998). Pride and a desire not to appear 
weak or non-macho may also be obstacles of treatment (Rose et al. 2000). It is possible 
that medicines are used, to some extent, when their use does not conflict with anything 
that has higher priority. This may also be visible in our study, which suggested that 
“frustration with treatment” (including aspects of lifestyle changes, health centre visits 
and inadequately effective medication) is associated with intentional non-compliance. If 
some unhealthy living habits are more important than health itself, there will be a 
priority conflict. From the patient’s perspective, medication should be so effective as to 
make the modification of lifestyle unnecessary. The treatment of hypertension may also 
take time and require visits to the health centre, but if the priority of health is low, it 
might be difficult to accept this, because there would be more important things to do. 
   Similarly, costs as a reason for intentional non-compliance (Delgado 2000) may be 
associated with priority conflicts. Some patients might consider it more important to 
buy e.g. hobby equipment, fashionable clothes or delicacies than medicines. 
   Furthermore, it is possible that medicines are used more regularly prior to scheduled 
blood pressure measurements (white coat compliance (Feinstein 1990)), because 
patients try to please health care professionals or to hide their non-compliant/non-
 concordant behaviour. In this situation, one of the patients’ high priorities is to give a 
positive image about him/herself to health care professionals. 
 
Ethical/moral or religious values 
   Our modern medicine has been built to rely on values. Sometimes the values of 
modern medicine and the patient differ but both of these sets of values are essential 
rules of treatment. The reasons for non-compliance may be related to ethical/moral or 
religious values of life, in which it is not meaningful to speak about ‘compliance’, but 
rather about ‘concordance’. In Finland, there are different minorities that belong to this 
group, and several immigrants groups have further increased the multiplicity of these 
groups.  In this category, it is essential to understand that these are the real values of the 
patient. It is therefore important to identify the situations where this category have been 
used as an excuse for refusing treatment, which in reality involve a problem in the 
priorities of life.  
   This category includes the patients with ethical/moral or religious values, for whom 
their own health and its treatment are a matter of high priority, but who find certain 
treatment methods unacceptable. An example of this might be Jehovah’s Witnesses, 
who refuse blood transfusion (Gyamfi et al 2003). It has also been reported that pork- 
and beef-derived gelatin and/or stearic acid, which are used as inert components in some 
drugs, are unacceptable to some patients in the Muslim, Orthodox Christian, and 
Seventh Day Adventist faiths (Sattar et al 2004). In birth control some people cannot 
accept methods that have postfertilization effects, such as intrauterine devices, hormonal 
emergency contraception and oral contraceptives (Larimore 2000, Larimore and 
Stanford 2000, Kahlenborn et al 2002, Stanford and Mikolajczyk 2002). It has been 
found in Finland that, of several therapeutic classes gynecological patients (the main 
subgroup was oral contraceptives) received least counseling from pharmacists (Vainio 
et al 2002). Furthermore, future embryonic stem cell treatments are considered non-
acceptable for those patients who find that a patient’s sickness should not be healed 
with a method that requires the life of a human embryo to be destroyed.  
   If these ethical/moral or religious values are combined with the patient’s view that 
health is not a high-priority matter, the case does not belong to this category, but to the 
 priorities of life category. An example of this might be a patient holding a view of 
predestination. For example, if the day of death is unchangeable, actions to improve 
one’s health might seem unnecessary. However, this view conflicts with all findings of 
modern medicine showing that a group of patients taking a certain medicine survive 
longer than another group of patients taking placebo. And even if the day of death is 
unchangeable, from a patient’s view, is the quality of life unchangeable? Preventing a 
heart attack or stroke ten years before death might be very beneficial for the quality of 
life.  
 
Between  intentional and non-intentional non-compliance and non-concordance 
   Intentional and non-intentional non-compliance can also be partly simultaneous. If the 
taking of medicines is not so important, other things fill up the mind, and it is easy to 
forget to take the medicine (Barber 2002). Simultaneous memory problems in 
intentional non-compliance and non-concordance may be more like secondary memory 
problems, which are not real memory problems. To clarify this possibility, the patient 
with memory problems should be asked about the attitudes and opinions of the 
perceived importance of medication-taking. However, the reliability of interview-based 
self-reports has been found to be problematic (Garber et at 2004), and future studies 
need to find more suitable techniques for interviews or e.g. develop questionnaires to 
replace in-depth interviews. Clarification of the main reason for non-compliance/non-
concordance is important both in medical practice and in research. However, in research 
it is a potential source of bias if patients with intentional behaviour and memory 
problems are misclassified in both groups in statistical analyses.  
 
Motivation  
   The connection between motivation and compliance and concordance is interesting 
and involves elements that are related to different types of non-compliance and non-
concordance. If life is depressing, the patient may lack motivation for many things, 
including medication-taking and this probably belongs to the disease category. If the 
priorities of life are not in order, there might not be motivation to take medication, i.e. 
its priority is low and in conflict with the higher priorities, and this may easily lead to 
 secondary memory problems. It is also possible that health care professionals do not 
motivate patients enough, and the patient does not understand the importance of 
antihypertensive medication and has individualistic ways of taking care of his/her health 
by using his/her own methods and partly or completely neglects the medical regimen. 
 
Applications of the classificatory model  
   The classification of non-compliance and non-concordance helps us to understand the 
complex phenomena of compliance and concordance, which is essential for achieving 
progress in research. Although the understanding of non-compliance/non-concordance 
is essential, it must be borne in mind that there are also other reasons for failure in 
treatment. An example of this could be a study on resistant hypertension patients, for 
whom the reason was found in 91% of the cases (Yakovlevitch and Black 1991). The 
most common reasons for resistant hypertension were: inadequate dosage or failure to 
prescribe antihypertensive drugs according to indication (43%), intolerable adverse drug 
effects despite several attempts with different drugs (half of the cases were also 
associated with non-compliance) (14%), secondary hypertension (11%), non-
compliance (10%), misinterpretation of psychological or physical signals as adverse 
drug effects of antihypertensive drugs (8%). In their study, 53% of patients had their 
blood pressure in control and the situation was clearly improved in another 11% of 
patients. Profound understanding of non-compliance/non-concordance combined with 
effective and adequate treatments is needed for success in medical practice. 
   The classificatory model sheds light on both the compliance and concordance 
theories, offering a possibility to develop methods of measurement that take into 
account the classification of phenomenona which should be considered an essential part 
of any seriously taken method of measurement. 
 7   CONCLUSIONS 
 
   This study examined compliance phenomenon and patient-perceived problems in the 
treatment of Finnish hypertensive patients. The following conclusion can be drawn: 
 
1. Patient-perceived problems concern practically every patient with antihypertensive 
drug therapy in Finnish primary health care.  
2. Intentional non-compliance with antihypertensive medication is associated with 
patient-perceived problems in the areas of everyday life related problems, health 
care system related problems and patient-related problems.  
3. Poor control of blood pressure with antihypertensive drug therapy is associated with 
patient-perceived everyday life-related problems, hopeless attitude towards 
hypertension and frustration with treatment. The association between blood pressure 
control and compliance was problematic to establish. 
4. The classifying model of non-compliance and non-concordance, which was created, 
categorizes the complex phenomenon into several entities and helps in 
understanding non-compliance. 
 
   The hypertension-related findings of this study show that the treatment of 
hypertensive patients in Finland is far from optimal. The system of health care has many 
important targets, especially in the areas associated with non-compliance or poor 
outcome of treatment. These targets include reorganization of patient services as more 
patient-friendly, change of attitudes among health care professionals into a more 
supportive direction and development of ways to share more effective and tailored 
individualistic information. Both teamwork between health care professionals and 
education about the health care professional-patient relationship is needed to achieve 
better understanding of patients’ ways of thinking and, correspondingly, to educate the 
patient better about health-related information. The follow-up of hypertensive as well as 
other chronic patients should be arranged properly. This type of development naturally 
requires more resources, but these resources of our health care should also be used more 
effectively. 
     The findings of this study related to the compliance theory are challenging to both 
compliance and concordance research. First, by dividing non-compliance into nine 
different sub-phenomena, which help us to understand this complex phenomenon more 
profoundly. Second, they challenge future research to study each of these phenomenona 
so that better treatment outcomes could be achieved in medical practice.  
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APPENDIX I: 
QUESTIONNAIRE IN THE PHARMACY-BASED STUDY 
 
 
Kuopion yliopisto  
Sosiaalifarmasian laitos 
Toukokuu 1996 
 
 
 
Arvoisa vastaanottaja 
 
 
 
Teemme tutkimusta verenpainetaudin lääkehoidosta. Tutkimuksemme tavoitteena on 
selvittää verenpainetaudin lääkehoitoon liittyviä ongelmia lääkkeen käyttäjän 
näkökulmasta. Tutkimuksen tuloksia on tarkoitus hyödyntää verenpainehoidon 
suunnittelussa ja lääkitykseen liittyvässä neuvonnassa. 
 
 
Toivomme Teidän ystävällisesti vastaavan oheisiin kysymyksiin tarkasti ja     
huolellisesti sekä palauttamaan kyselyn oheisessa kirjekuoressa (postimaksu on jo 
maksettu) mahdollisimman pian, mutta kuitenkin viimeistään kahden viikon   
kuluessa. Kaikki antamanne tiedot käsitellään ehdottoman vaitiolovelvollisuuden 
pohjalta ja vastauksianne käytetään vain tutkimuskäyttöön. 
 
 
Tutkimukseen osallistuneiden kesken arvomme 50 kappaleen Sydänlääke oppiaita. 
Oppaan ovat kirjoittaneet Sydäntautiliiton asiantuntijalääkäri Jyrki Olkinuora ja   
dosentti Timo Klaukka. Opas sisältää yleistä tietoa sydänsairauksista ja   
sydänlääkkeistä. Mikäli haluatte osallistua arvontaan täyttäkää oheinen erillinen 
arvontalomake ja palauttakaa myös se vastauskuoressa. Arvontalomakkeet erotellaan 
vastauslomakkeista välittömästi niiden saavuttua, eikä henkilötietoja liitetä 
tutkimustietoihin missään vaiheessa. 
 
 
Jos teillä on kysyttävää tutkimuksesta, voitte soittaa professori Hannes Enlundille     
puh: 971-162 500 tai proviisoriopiskelija Erkki Jokisalolle puh 981-311 2019. 
 
 
 
Yhteistyöstä jo etukäteen kiittäen 
 
 
 
 
Hannes Enlund  Erkki Jokisalo 
professori   proviisoriopiskelija
Kuopion yliopisto 
Sosiaalifarmasian laitos 
Touko-elokuu 1996 
 
VERENPAINETAUDIN LÄÄKEHOITO 
 
 
Vastausohjeet: Olkaa hyvä ja vastatkaa jokaiseen kysymykseen kirjoittamalla vastaus selvästi sille 
varattuun kohtaan tai rengastamalla sopivaa vaihtoehtoa vastaava numero. 
 
 
1. Milloin Teillä ensimmäisen kerran todettiin 
kohonnut verenpaine?   
vuosi 
 
 
2. Milloin Teille aloitettiin ensimmäisen ker-
ran verenpaineen lääkehoito?  
 
vuosi 
 
 
 
3. Kuinka usein käytte lääkärin vastaanotolla 
verenpainetautinne takia?                                
 
 
 
 
4. Kuinka usein lääkäri tai hoitaja mittaa   
verenpaineenne? 
 
 
 
5. Muistatteko viimeisimmän lääkärin tai hoi-
tajan mittaaman verenpainelukeman? 
 
             /              (mmHg),  
milloin mitattu                             kuussa 19       .  
 
 
6. Mittaatteko verenpainetta omalla mitta-
rilla? 
 
1 minulla ei ole mittaria (siirtykää  
kysymykseen numero 8) 
2 kerran päivässä tai useammin 
3 muutaman kerran viikossa 
4 muutaman kerran kuukaudessa 
5 harvemmin 
6 en käytä verenpainemittaria 
 
 
 
 
7. Mikä oli viimeisin mittaamanne veren-
painelukema? 
 
             /              (mmHg),  
milloin mitattu                             kuussa 19       .  
 
 
8. Pystyttekö mielestänne tuntemaan milloin 
verenpaineenne on koholla? 
 
1 en 
2 kyllä 
 
 
9. Onko kohonnut verenpaine aiheuttanut 
Teille jotain oireita? 
 
a) ennen lääkehoidon aloittamista 
1 ei 
2 kyllä, mitä?                                             
b) lääkehoidon aloittamisen jälkeen 
1 ei 
2 kyllä, mitä?                                             
 
 
10. Millainen verenpaineenne taso on mieles-
tänne ollut viimeksi kuluneen vuoden (12 kk) 
aikana? 
 
1 huono 
2 kohtalainen 
3 hyvä 
 
11. Onko terveydentilanne nykyisin mieles-
tänne yleensä 
 
1 hyvä 
2 melko hyvä 
3 kohtalainen 
4 melko huono 
5 huono 
 
1. 
2. 
3. 
4. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
 
 
12. Montako vuotta olette käyttänyt verenpainelääkkeitä?   yhteensä              vuotta 
 
13. Mitä verenpainelääkkeitä käytätte tällä hetkellä? 
Mistä vuodesta lähtien 
 Lääkkeen nimi   Annostus olette käyttänyt 
     
     
     
     
 
14. Mitä muita lääkärin määräämiä lääkkeitä käytätte tällä hetkellä? 
      Lääke   Käyttötarkoitus 
    
   
   
   
   
   
   
   
 
15. Ovatko käyttämänne verenpainelääkkeet aiheuttaneet Teille epämiellyttäviä tuntemuksia tai 
haittavaikutuksia? 
 
1 ei (siirtykää kysymykseen numero 17) 
2 kyllä 
 
Minkälaisia epämiellyttäviä tuntemuksia tai haittavaikutuksia verenpainelääkkeet ovat Teille 
aiheuttaneet? Miten epämiellyttäviä ne ovat olleet? Mainitkaa lääkkeen nimi, jos pystytte yhdistä-
mään sen tuntemukseen. 
 
Haittavaikutus (lääkkeen nimi)   erittäin epä- kohtalaisen hieman jokseenkin 
miellyttävä epämiellyttävä epämiellyttävä harmiton 
                                                                         1  2  3 4  
                                                                         1  2  3 4  
                                                                         1  2  3 4  
                                                                         1  2  3 4 
                                                                         1  2  3 4 
                                                                         1  2  3 4  
  
 
 
16. Onko lääkäri muuttanut lääkitystänne 
haittavaikutusten takia? 
 
1 ei ole 
2 annostusta on pienennetty 
3 lääkitys on lopetettu, uutta ei tilalle 
4 lääkitys on lopetettu, uusi lääke tilalle 
5 muuta, mitä? 
  
 
                                                                
 
17. Onko lääkäri muuttanut lääkitystä muun 
syyn kuin haittavaikutusten takia? 
 
1 ei ole 
2 on lisätty annostusta 
3 on lisätty uusi lääke 
4 muuta, mitä? 
 
 
 
18. Onko lääkäri vaihtanut verenpainelääk-
keitänne viimeisen vuoden aikana? 
 
1 ei 
2 kyllä  
 
19. Onko lääkkeiden otto mielestänne vaikea 
muistaa? 
 
1 ei 
2 joskus 
3 usein 
 
20. Kuinka usein Teiltä on keskimäärin jäänyt 
verenpainelääkkeenne (tai jokin niistä) otta-
matta viimeksi kuluneen kuukauden aikana? 
 
1 ei kertaakaan 
2 kerran tai pari kuukaudessa 
3 kerran viikossa 
4 monta kertaa viikossa 
 
21. Aiheuttaako verenpainelääkkeen oton 
sovittaminen päivärytmiin hankaluuksia 
(työn, matkustelun tai muun sellaisen syyn 
takia)? 
 1 ei lainkaan 
 2 joskus 
 3 usein 
 
 
 
 
22. Onko verenpaineen lääkehoito haitannut 
vapaa-ajan harrastuksianne? 
 
1 ei 
2 joskus 
3 usein 
 
 
23. Onko Teidän ollut pakko luopua jostakin 
mukavista asioista (esimerkiksi harrastuk-
sista) verenpainetautinne vuoksi? 
 
1 ei 
2 kyllä, mistä? 
 
 
24. Oletteko koskaan kokeillut itse pärjäätte-
kö vähemmillä verenpainelääkkeillä? 
 
1 en 
2 joskus 
3 usein 
 
 
25. Onko lääkäri koskaan kokeillut pärjäätte-
kö vähemmillä verenpainelääkkeillä? 
 
1 ei 
2 kerran 
3 useamman kerran 
 
 
26. Jos käytätte verenpainelääkkeitä oman 
mielenne mukaisesti, niin mitkä seuraavista 
ovat mielestänne tärkeimmät syyt siihen 
(1-3 syytä)? 
 
1 käytän lääkkeitä lääkärin antaman  
ohjeen mukaan 
2 lääkäri määräsi lääkkeitä liian paljon 
3 lääkäri määräsi lääkkeitä liian vähän 
4 lääke aiheutti haittavaikutuksia, joten  
5 en mielestäni tarvitse lääkkeitä joka  
päivä yhtä paljon 
6 lääke jäi uusimatta, joten en käytä sitä 
7 lääkkeiden jatkuva nauttiminen ei ole  
8 muu syy, mikä? 
                                                              
 
Käännä 
  
 
 
27. Onko vaikea olla verenpainepotilas? 
 
1 ei 
2 joskus 
3 usein 
 
 
28. Ovatko verenpainelääkkeiden aiheut-
tamat kustannukset Teille taloudellisesti 
 
1 suuri rasite 
2 kohtalainen rasite 
3 vähäinen rasite 
4 täysin merkityksetön rasite 
 
 
29. Oletteko mielestänne saanut tarpeeksi tietoa verenpainelääkkeiden 
  
 
 
En 
 
Kyllä 
 
En osaa 
sanoa  
annostuksesta ..................................................... 
 
1 
 
2 
 
3  
vaikutustavasta ................................................... 
 
1 
 
2 
 
3  
haittavaikutuksista ............................................... 
 
1 
 
2 
 
3  
lääkityksen kestosta ............................................ 
 
1 
 
2 
 
3  
lääkityksen tarpeellisuudesta............................... 
 
1 
 
2 
 
3  
lääkkeiden ja alkoholin yhteisvaikutuksista ......... 
 
1 
 
2 
 
3  
lääkkeiden säilytyksestä ......................................
 
1 
 
2 
 
3  
yhteisvaikutuksista muiden lääkkeiden kanssa ... 
 
1 
 
2 
 
3 
 
 
30. Mitkä asiat ovat jääneet epäselviksi lääkityksenne suhteen? 
 
 
 
 
 
 
31. Mikä on sukupuolenne? 
 
1 mies 
2 nainen 
 
 
32. Mikä on syntymävuotenne?     19  
 
 
33. Mikä on siviilisäätynne? 
 
1 naimisissa 
2 avoliitossa 
3 naimaton 
4 asumuserossa tai eronnut 
5 leski 
 
 
 
 
 
 
34. Mikä on koulutuksenne? 
(voitte rengastaa useamman kuin yhden 
vaihtoehdon) 
 
1 kansakoulu 
2 keskikoulu 
3 lukio 
4 ammattikoulu 
5 keskiasteen tutkinto 
6 korkeakoulututkinto 
 
 
 
 
 
 
 
 
KIITOS VASTAAMISESTA! 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX II: 
QUESTIONNAIRES IN THE PRIMARY CARE BASED STUDY 
 
  
Verenpainepotilaan hoito terveyskeskuksessa 1996 - 97 
 
 
KYSELY VERENPAINEPOTILAALLE  
 
 
 
 
Arvoisa potilas 
 
 
Kiinnitämme vuosina 1996 - 97 terveyskeskuksessamme erityistä huomiota veren-
paineen hoitoon.  Osallistumme valtakunnalliseen Verenpainepotilaan hoito 
terveyskeskuksessa 1996 - 97 -tutkimukseen, johon meidän lisäksemme osallistuu    
29 muuta terveyskeskusta eri puolilta Suomea. Teemme tutkimusyhteistyötä Kuopion 
yliopiston yleislääketieteen yksikön kanssa. 
 
Jotta tutkimus meidän terveyskeskuksessamme onnistuisi hyvin, pyydän Teitä  
täyttämään nämä kyselylomakkeet huolellisesti. Täyttäkää molemmat lomakkeet         
(osa I ja II) kotona. Ottakaa molemmat osat mukaanne hoitajan vastaanotolle. 
Tuodessanne kyselyn osa I:n hoitajan vastaanotolle, voitte yhdessä täydentää 
mahdollisesti puuttuvat tiedot ja hoitaja täyttää lomakkeen viimeiselle sivulle     
laboratorio- yms. tutkimustulokset.   
 
Kyselyn toisessa osassa (osa II) voitte tuoda esiin mielipiteitänne verenpaineenne 
hoidosta. Pyydän Teitä sulkemaan osa II:n oheiseen Kuopion yliopiston kirjekuoreen       
ja tuomaan sen hoitajalle postitusta varten. Kirjeenne avataan vasta yliopistossa.  
 
Terveyskeskuksemme ei saa yliopistolta käyttöönsä yksittäisten potilaiden, kuten    
Teidän vastauksia. Sen sijaan terveyskeskuksemme saa paikkakuntamme kaikkien 
tutkittavien potilaiden vastausten keskiarvot. Näiden tulosten perusteella voimme   
kiinnittää huomiota terveyskeskuksemme verenpaineen hoidossa mahdollisesti   
ilmeneviin puutteisiin ja parantaa näin potilaittemme hoidon laatua. 
 
Noudatamme kaikkien tutkimustietojen suhteen ehdotonta vaitiolovelvollisuutta. Omat 
laboratorio- ja seurantakäyntinne tulokset saatte hoitajalta ja hoitavalta lääkäriltänne.  
 
Tullessanne hoitajan vastaanotolle, ottakaa mukaan kaikkien lääkärin     
määräämien ja nykyisin käyttämienne lääkkeiden reseptit (tai lääkepurkit, mikäli 
ette löydä reseptejänne). Ottakaa mukaan myös Kela-korttinne ja 
verenpainekorttinne. 
 
 
 
 
                                                              
Tutkimuksen vastuulääkäri (leima) 
 
 
 
 
 
 
Arvoisa potilas 
 
Verenpaineen hyvä hoito on ensiarvoisen tärkeää torjuttaessa sydän- ja verisuonitauteja, 
erityisesti aivohalvauksia ja sepelvaltimotautia (sydäninfarkteja). 
 
Tässä tutkimuksessa pyrimme saamaan mahdollisimman seikkaperäisen kuvan verenpaineen 
hoidon toteutumisesta Suomessa. Teidän panoksenne tämän tutkimuksen onnistumiseksi on 
ratkaiseva. Siksi pyydämme Teitä täyttämään huolellisesti nämä lomakkeet, sekä osan I että   
osan II. 
 
Erityisesti kyselylomakkeen osassa II esitämme osin arkaluontoisiakin kysymyksiä, joihin 
toivomme Teidän vastaavan rehellisesti ja vilpittömästi. Antamanne tiedot voivat olla      
ratkaisevia pyrittäessä parantamaan verenpainepotilaan hoitoa maassamme. Teidän 
vastauksenne tulevat näiltä osin vain yliopiston tutkijoiden käyttöön, eivätkä mene 
terveyskeskukseen. Luonnollisesti myös yliopistossa noudatetaan vastauksienne suhteen 
ehdotonta vaitiolovelvollisuutta.  
 
 
Vastausohjeet 
 
Rengastakaa vastausvaihtoehdoista vain yksi, ellei kysymyksen ohjeissa ole muuta 
mainittu, esimerkiksi 
 
 Hoitaako verenpainettanne pääasiassa 
  1    terveyskeskuslääkäri 
  2    työterveyslääkäri terveyskeskuksessa 
  3    muu työterveyslääkäri 
  4    yksityislääkäri 
  5    en ole lääkärin hoidossa verenpaineeni vuoksi  
 
Avoimissa kysymyksissä kirjoittakaa vastaus sille varattuun tilaan. Esimerkiksi 
 
 Ovatko tällä hetkellä käytössänne olevat verenpainelääkkeet aiheuttaneet Teille mitään 
 haittavaikutuksia 
  1    ei 
  2    kyllä, mikä lääke ja millaisia haittavaikutuksia? 
 
 Lääke         Haittavaikutus 
 
Atenol   kylmät jalat 
   
                                      
  
Mielipidekysymyksissä (tämän lomakkeen kysymys 35 ja koko osa II) valitkaa jokaisen 
väittämän kohdalla omaa mielipidettänne lähinnä vastaava numero. Esimerkiksi 
 
                      Täysin    Jokseenkin  Jokseenkin  Täysin  
                      samaa    samaa           eri                  eri 
                      mieltä     mieltä            mieltä            mieltä 
Terveyskeskuksessa on liian vähän veren- 
paineen mittausaikoja.     1            2        3               4
     
 
Vastattuanne sulkekaa osa II oheiseen kirjekuoreen ja tuokaa molemmat lomakkeet 
tullessanne hoitajan vastaanotolle. Hoitaja täyttää laboratorio- ym. tutkimustulokset       
osan I takasivulle. 
 
 
OSA I 
 
ALOITTAKAA VASTAAMINEN TÄSTÄ: 
1. Onko Teillä omaa lääkäriä? 
1 kyllä 
2 ei 
 
2. Käyttekö yleensä verenpaineasioissanne  
a) yhden (saman) lääkärin luona? 
1 kyllä 
2 en 
b) yhden (saman) terveydenhoitajan luona? 
1 kyllä 
2 en 
 
3. Hoitaako verenpainettanne pääasiassa? 
1 terveyskeskuslääkäri 
2 työterveyslääkäri terveyskeskuksessa 
3 muu työterveyslääkäri 
4 yksityislääkäri 
5 en ole lääkärin hoidossa verenpaineeni 
vuoksi 
 
4. Kuinka kauan Teillä on ollut verenpaine-      
tauti tai koholla oleva verenpaine?  
1  alle puoli vuotta 
2 puoli vuotta - 1 vuosi 
3  yli 1 vuosi - 2 vuotta 
4 yli 2 vuotta - 5 vuotta 
5  yli 5 vuotta - 10 vuotta 
6 yli 10 vuotta 
 
5. Käyttekö verenpaineenne vuoksi  
a) lääkärissä 
1 6 kertaa vuodessa tai useammin 
2 4 - 5 kertaa vuodessa 
3 2 - 3 kertaa vuodessa 
4 kerran vuodessa 
5 noin joka toinen vuosi 
6 harvemmin 
  
a) terveydenhoitajan luona 
1 10 kertaa vuodessa tai useammin 
2 6 - 9 kertaa vuodessa 
3 4 - 5 kertaa vuodessa 
4 2 - 3 kertaa vuodessa 
5 kerran vuodessa 
6 harvemmin 
 
6. Oletteko hoitavan lääkärinne kanssa       
sopinut verenpainearvosta, johon Teidän 
hoidossanne olisi pyrittävä? 
1 kyllä on sovittu, tavoitteena on päästä  
  arvoon                  /                  mmHg 
2 on puhuttu verenpaineen alentamisen 
tarpeesta ilman tarkkaa rajaa  
3  ei ole sovittu mitään 
7. Käytättekö tällä hetkellä verenpaine-      
lääkkeitä? 
 
1  kyllä 
2  en käytä (siirtykää kysymykseen 10) 
 
  
8. Mitä verenpainelääkkeitä käytätte tällä        
hetkellä (tarkistakaa nimet ja annostukset    
pakkauksista tai resepteistä)? 
  
Lääke Vahvuus (mg) Annostus   
 
(Esim. Atenol  100 mg 1 x 1) 
 
     
     
     
     
 
9. Ovatko tällä hetkellä käytössänne olevat 
verenpainelääkkeet aiheuttaneet Teille mitään 
haittavaikutuksia? 
 
1  ei  
2 kyllä, mikä lääke ja millaisia haitta- 
 vaikutuksia? 
 
Lääke        Haittavaikutus 
   
   
   
 
10. Onko lääkäri keskustellut Teidän kanssanne 
seuraavista verenpaineenne hoitoon liittyvistä 
asioista? 
 
 Kyllä  Ei        Ei koske 
             minua 
 
Vähärasvainen ruoka 1 2 3 
Laihduttaminen 1 2 3 
Alkoholin käyttö  1 2 3 
Tupakoinnin lopettaminen 1 2 3 
Säännöllinen liikunta 1 2 3 
Verenpainelääkkeiden  
säännöllinen käyttö 1 2 3  
 
Säännölliset  
verenpainekontrollit 1 2 3 
 
Suolan käytön  
vähentäminen 1 2 3 
 
  
 
 
 
11. Onko terveydenhoitaja keskustellut Teidän 
kanssanne seuraavista verenpaineenne      
hoitoon liittyvistä asioista? 
 
 Kyllä Ei  Ei koske 
 minua 
Vähärasvainen ruoka  1 2 3 
Laihduttaminen  1 2 3 
Alkoholin käyttö  1 2 3 
Tupakoinnin lopettaminen 1 2 3 
Säännöllinen liikunta  1 2 3 
Verenpainelääkkeiden 
säännöllinen käyttö  1 2 3 
 
Säännölliset  
verenpainekontrollit  1 2 3 
 
Suolan käytön  
vähentäminen  1 2 3 
 
12. Millainen verenpaineenne on ollut useim-
missa mittauksissa viimeksi kuluneen vuoden   
(12 kk) aikana? 
 
1 aivan liian korkea 
2 hieman liian korkea 
3 melko hyvä 
4 erittäin hyvä 
 
 
13. Oletteko käyttänyt viimeksi kuluneen    
vuoden (12 kk) aikana verenpainelääkkeitä 
vähemmän kuin mitä lääkäri on määrännyt? 
   
1 en  
2 kyllä, joskus 
3 kyllä, usein, millaisissa tilanteissa ja 
miksi? 
 
 
14. Onko Teiltä koskaan mitattu kolesterolia? 
 
1 ei ole mitattu (siirtykää kysymyk- 
seen 22) 
2 on mitattu, se on ollut normaali 
3 on mitattu, kolesterolin on todettu  
olevan koholla 
4 on mitattu, en tiedä tulosta 
 
 
15. Milloin Teiltä viimeksi mitattiin kolesteroli- 
arvo ja mikä oli tulos? 
 
              kuussa 19       ,  arvo oli           mmol/l 
                   (arvioikaa, jos ette muista) 
 
 
 
 
16. Oletteko sopinut hoitavan lääkärinne kanssa 
Teidän tavoitteena olevasta kolesteroli-  
arvostanne? 
 
1 kyllä on keskusteltu, tavoitteena on   
 kohdallani päästä lukemaan_____mmol/l 
2 on puhuttu kolesterolin alentamisen  
tarpeesta ilman tarkkaa tavoitetta 
3 ei ole keskusteltu kolesterolin alentamisen  
 tarpeesta 
 
 
17. Miten hoidatte korkeaa kolesterolianne       
(tässä voitte valita useita kohtia)? 
 
 1 en mitenkään 
 2 ruokavaliolla 
 3  lääkkeillä 
 4  muulla tavalla, millä?   
 
 
18. Käytättekö tällä hetkellä kolesterolia       
alentavia lääkkeitä? 
 
1  kyllä 
2  en käytä (siirtykää kysymykseen 22) 
 
 
19. Mitä kolesterolia alentavia lääkkeitä käytätte 
tällä hetkellä? 
 
Lääke Vahvuus (mg) Annostus   
     
     
     
     
                     
 
20. Ovatko tällä hetkellä käytössänne olevat 
kolesterolia alentavat lääkkeet aiheuttaneet Teille 
mitään haittavaikutuksia? 
 
1  ei  
2 kyllä, mikä lääke ja millaisia haitta- 
 vaikutuksia? 
 
Lääke                     Haittavaikutus 
   
   
   
 
 
 
21. Oletteko käyttänyt viimeksi kuluneen    
vuoden (12 kk) aikana kolesterolia alentavia 
lääkkeitä vähemmän kuin mitä lääkäri on 
määrännyt? 
 
1  en 
2  kyllä, joskus 
3  kyllä, usein, millaisissa tilanteissa ja 
miksi?  
 
 
 
22. Ovatko lääkkeiden kokonaiskustannukset 
(kaikkien lääkkeiden kustannukset) vaikutta-    
neet viimeksi kuluneen vuoden (12 kk) aikana 
lääkkeiden käyttöönne? (Tässä voitte valita  
useita vaihtoehtoja) 
 
1 ei ole vaikuttanut lääkkeiden käyttöön 
  2 olen joutunut harventamaan lääkkei-  
  den hankkimista, mitä lääkkeitä? 
 
  
 3 olen jättänyt ostamatta jonkun / joitakin 
   lääkkeitä kokonaan, mitä lääkkeitä 
 
  
 4 olen joutunut luopumaan jostakin 
  muusta hankinnasta korkeiden 
  lääkekustannusten takia, mistä? 
 
 
 
23. Mitä muita lääkärin määräämiä lääkkeitä    
kuin verenpainelääkkeet ja kolesterolilääk-      
keet olette käyttänyt vähintään kahdesti     
viimeksi kuluneen viikon (7 vrk) aikana? 
Merkitkää erityisen tarkasti käyttämänne kipu-    
ja särkylääkkeet sekä sydän- ja rytmihäiriö-
lääkkeet. 
 
Lääke  Käyttötarkoitus Annostus 
     
     
     
     
     
     
     
     
 
 
 
 
24. Mitä ilman lääkemääräystä saatavia lääkkeitä 
olette käyttänyt vähintään kahdesti viimeksi          
kuluneen viikon (7 vrk) aikana? Merkitkää     
erityisen tarkasti käyttämänne kipu- ja 
särkylääkkeet.  
 
Lääke  Käyttötarkoitus 
   
   
   
   
 
 
25. Onko Teillä koskaan todettu tai hoidettu mitään 
seuraavista sairauksista? Rengastakaa kaikki 
sairautenne. 
 
 
1 sepelvaltimotauti, angina pectoris  
2 sydäninfarkti     
3 sydämen vajaatoiminta   
4 muu sydänvika (läppävika, rytmihäiriö) 
5 aivohalvaus, aivoverenvuoto   
6 muu aivoverenkierron häiriö (TIA)  
7 sokeritauti    
9 silmän verkkokalvon verenvuoto tai   
10 kilpirauhasen vajaatoiminta   
11 ohitusleikkaus tai pallolaajennus  
12 munuais- tai virtsatiesairaus (toistuvia  
virtsatietulehduksia, munuaiskivi)  
13 kihti      
14 metabolinen oireyhtymä   
15 muu sairaus (sairauksia), mikä? 
 
 
 
 
 
26. Tarkistakaa omasta Kela-kortistanne, mitkä 
seuraavista erityiskorvattaviin lääkkeisiin 
oikeuttavista numeroista Teiltä löytyvät ja 
rengastakaa numerot. 
 
103    104    201    205    206    207    211    212 
 
 
  
27. Alkoholin käyttö 
 
Laskekaa tarkkaan, kuinka monta annosta     
alkoholia käytitte äskettäin tavanomaisen viikon 
aikana.  
 
Yksi annos alkoholia = pullollinen olutta tai yksi    
grogi (4 cl) viinaa (esim. Koskenkorva, vodka,      
viski, rommi, gini tai konjakki) tai 12 cl valko-            
tai punaviiniä tai 8 cl väkevää viiniä (esim. Gambina, 
Sorbus, Vinetto).  
 
Huom! yksi pullo valko- tai punaviiniä = 6       
annosta, pullo väkevää viiniä = 9 annosta, puolen 
litran pullo viinaa = 12 annosta. 
 
1 en ole koskaan käyttänyt alkoholia 
2 en ole viimeksi kuluneen vuoden 
 aikana enää käyttänyt alkoholia 
3 käytän alkoholia ja keskimääräinen  
        kulutukseni viikossa on: 
 
4 alle 1 annos 
5 1-2 annosta 
6 3-5 annosta 
7 6-9 annosta 
8 10-14 annosta 
9 15-21 annosta 
10 22-28 annosta 
11 29 annosta tai enemmän 
 
 
28. Tupakointi 
 
1 en ole koskaan tupakoinut 
2 olen lopettanut 
Kuinka monta vuotta ehditte tupakoida  
  ennen lopettamistanne? 
               vuotta 
3  tupakoin satunnaisesti 
4  tupakoin säännöllisesti 
Kuinka monta savuketta/sikaria/  
piipullista poltatte keskimäärin päivässä? 
                    päivässä 
 
 
29. Lakritsin syönti voi vaikuttaa veren-
paineeseen. Syöttekö lakritsia? 
 
1  päivittäin 
2  pari - kolme kertaa viikossa 
3  kerran viikossa tai harvemmin 
4  en syö lakritsia lainkaan 
 
 
 
 
 
 
 
 
30. Siviilisäätynne? 
 
1 naimaton 
2 avio- tai avoliitossa 
3 eronnut, asumuserossa 
4 leski 
 
 
31. Pohjakoulutuksenne? 
 
1 kansa-, kansalaiskoulu (tai osia niistä) 
2 keski-, peruskoulu (tai osia niistä) 
3 lukio ja/tai ammatillinen    
  koulutus/tutkinto 
4 korkeakoulu, yliopisto  
 
 
32. Kuinka monta vuotta yhteensä olette käynyt 
päätoimisesti koulua tai opiskellut elämänne 
aikana?         
                                vuotta 
 
 
33. Mikä on työtilanteenne tällä hetkellä? 
 
1 palkansaaja, koko- tai osapäivätyössä 
2 maatalousyrittäjä, yrittäjä, ammatin-  
  harjoittaja tai näihin kuuluva perheen- 
  jäsen 
3 työtön, työllisyysvaroin työllistetty 
4 eläkkeellä 
5 opiskelemassa 
6 kotiäiti/-isä 
7 muu, mikä? 
 
 
34. Mikä on ollut pääasiallinen toimeentulonne 
viimeksi kuluneen vuoden aikana? 
 
1 omat palkka- tai yrittäjätulot 
2 eläketulot 
3 toisen perheenjäsenen tulot, säästöt,  
  pääomatulot, tms. 
4 opintoraha, opintolaina 
5 sairauspäiväraha, äitiyspäiväraha,  
vanhempainraha 
6 työttömyyspäiväraha (peruspäiväraha) 
7 ansiosidonnainen työttömyyspäiväraha  
8 kuntoutustuki  
9 muu, mikä?                                             
 
 
 
PYYDÄN TEITÄ VIELÄ OTTAMAAN KANTAA 
SEURAAVALLA SIVULLA ESITETTYIHIN      
ASIOIHIN.  
 
 
 
 
35. Seuraavassa on lueteltu tekijöitä, jotka saattavat vaikuttaa verenpaineenne hoitoon. Käykää       
seuraavat asiat kohta kohdalta läpi rengastaen kustakin väittämästä Teidän mielipidettänne vastaava    
numero (siis yksi numero joka riviltä). Mikäli jokin asia ei koske Teitä valitkaa vaihtoehto 5. 
 
 
Täysin Jokseenkin  Jokseenkin Täysin  Ei 
samaa samaa eri eri  koske 
mieltä mieltä mieltä mieltä  minua 
En ole saanut lääkäriltä kunnon ohjeita  
verenpaineeni hoitoon.   1 2 3 4 5 
 
Minulla on niin paljon vaivoja, etten jaksa kiinnittää 
huomiota verenpaineeseeni.   1 2 3 4 5 
 
Olen yrittänyt hoitaa verenpainettani parhaan  
taitoni mukaan.   1 2 3 4 5 
 
Minun on vaikea muistaa ottaa verenpainelääk- 
keeni säännöllisesti.   1 2 3 4 5 
 
Minun on vaikea harrastaa tarpeeksi liikuntaa 
laihtuakseni.   1 2 3 4 5 
 
Lääkärissä käynnit verenpaineeni vuoksi ovat 
jääneet oman harkintani varaan.  1 2 3 4 5 
 
Perheeni ja muut läheiseni eivät tue minua 
tarpeeksi verenpaineeni hoidossa.  1 2 3 4 5 
 
Verenpainettani vain seurataan aloittamatta  
hoitoa.    1 2 3 4 5 
 
Lääkärit eivät osaa antaa tarpeeksi yksityis- 
kohtaisia neuvoja, jotta laihtuisin.  1 2 3 4 5 
 
En muista aina käydä määräajoin terveyden- 
hoitajalla verenpaineeni vuoksi.  1 2 3 4 5 
 
Kohonnut verenpaine on nykyisessä elämän- 
tilanteessani toisarvoinen ongelma.  1 2 3 4 5 
 
En voi mitään lihavuudelleni, koska se on 
perinnöllistä.   1 2 3 4 5 
 
En laihdu, sillä hyvä ruoka on harvoja ilojani. 1 2 3 4 5 
 
Hoitajalla käynnit verenpaineeni vuoksi ovat 
jääneet oman harkintani varaan.  1 2 3 4 5 
 
 
Annan suostumukseni, että sairauskertomustietojani saa käyttää tähän verenpaineen hoito -    
tutkimukseen. 
 
1  annan suostumukseni   
2      en anna suostumustani  
 
 
 
 
 
Paikka ja aika    Allekirjoitus 
 
 
 
KIITOKSIA! 
 
 
 
HOITAJA TÄYTTÄÄ TÄMÄN SIVUN 
VERENPAINEPOTILAAN HOITO TERVEYSKESKUKSESSA 1996 
 
Potilaan nimi:_________________________________ Henkilötunnus:_____________-_________ 
 
Hoitava lääkäri: ___________________________________Terveyskeskus:________________________________________ 
 
                             
                           HOITAJAN SEURANTAKÄYNTI   ________/ ________/199____ 
Pituus:________cm            
       
 
Paino:  _______,___kg       
       
Vyötärön  
 ympärys _________cm     
                            
Lantion  
ympärys_________cm       
                                 
 
Pulssi: _________ /min 
 
Painon muutos viimeksi kuluneen 
vuoden (12 kk) aikana:                              1. Lisääntynyt                 kg          2. Vähentynyt                  kg     3. Pysynyt ennallaan 
 
Verenpaine:                  1. mittaus:                  /               mmHg                               2. mittaus:                 /                mmHg                             
 
LABORATORIOTUTKIMUKSET VIIMEKSI KULUNEEN VUODEN (12 KK) AIKANA + VUOSIKONTROLLI 
(Enintään kolme viimeistä arvoa. Jos koetta ei ole otettu viimeisen vuoden (12 kk) aikana, vuosikontrollin tulos.) 
 
POTILAAN VERENPAINEARVOT VUONNA 1996-97  
        (Enintään 10 mittaustulosta verenpainekortista tai sairauskertomuksesta kuvaten viimeisen vuoden (12 kk) tilannetta) 
 
Päiväys 
 
Verenpaine (mmHg) 
 
Päiväys 
 
Verenpaine (mmHg) 
       /      199 
 /         /      199 
 /  
       /      199 
 /         /      199 
 /  
       /      199 
  /        /      199 
  / 
       /      199 
  /        /      199 
  / 
       /      199 
  /        /      199 
  /
 
 1 
___ /___ /199_ 
2  
___ /___ /199_ 
 
3 
___ /___ /199_ 
Vuosikontrolli 
___ /___ 
/199 
B-Hb(g/l) 
 
 
 
 
 
 
 
 
 
MCV (fl) 
 
 
 
 
 
 
 
 
 
S-γ-GT (U/l) 
 
 
 
 
 
 
 
 
 
f-B-gluk (mmol/l) 
 
 
 
 
 
 
 
 
 
f-S-kol (mmol/l) 
 
 
 
 
 
 
 
 
 
f-S-HDL-kol (mmol/l) 
 
 
 
 
 
 
 
 
 
f-S-trigly (mmol/l) 
 
 
 
 
 
 
 
 
 
S-Na (mmol/l) 
 
 
 
 
 
 
 
 
 
S-K (mmol/l) 
 
 
 
 
 
 
 
 
 
f-S-krea (µmol/l) 
 
 
 
 
 
 
 
 
 
S-uraat (µmol/l) 
 
 
 
 
 
 
 
 
 
EKG (nauha tai kopio siitä) 
 
 
 
 
 
 
 
 
 
 
  Päiväys:________/________/199__       Verenpainehoitaja _________________________________________________ 
 
 
       KIITOS HUOLELLISUUDESTASI! 
 
 
 
Verenpainepotilaan hoito terveyskeskuksessa 1996 - 97 
 
KYSELY VERENPAINEPOTILAALLE          OSA II 
 
Vastattuanne tähän osaan (II), sulkekaa lomake oheiseen vastauskuoreen ja ottakaa suljettu kuori       
hoitajan vastaanotolle. 
 
Olkaa hyvä ja ottakaa kantaa seuraaviin väittämiin ajatellen omaa verenpaineenne hoitoa. Rengas-     
takaa kustakin väittämästä mielipidettänne vastaava numero (siis yksi numero joka riviltä).              
Mikäli jokin asia ei koske Teitä valitkaa vaihtoehto 5. 
 
Täysin Jokseenkin  Jokseenkin Täysin Ei 
samaa samaa eri eri koske 
mieltä  mieltä mieltä mieltä minua 
 
Olen erittäin tyytyväinen lääkärini tapaan hoitaa 
verenpainettani.    1  2 3  4  5 
 
Verenpaineeni hoito on yhtä juoksemista terveys- 
keskuksessa.    1  2 3  4  5  
 
Lääkärit vaativat minua muuttamaan liikaa elintapojani  
verenpaineeni vuoksi.    1  2 3  4  5 
 
En halua vaivata verenpaineellani terveyskeskusta,  
koska siellä on minua sairaampiakin hoidettavia.  1  2 3  4  5  
 
En ole käynyt viime aikoina mittauttamassa veren- 
painettani eikä siihen ole kiinnitetty terveyskeskuk- 
sessa sen enempää huomiota.   1  2 3  4  5 
 
Mittaan itse verenpaineeni, koska se on muiden  
mittaamana huomattavasti korkeampi.  1  2 3  4  5 
 
Elintapani eivät kuulu muille.    1  2 3  4  5 
 
Vähäsuolainen ruoka on minusta mautonta.  1  2 3  4  5 
 
Verenpainelääkkeeni eivät ole riittävän tehokkaita.  1  2 3  4  5 
 
Minulla ei ole varaa käyttää verenpainelääkkeitä 
niin paljon kuin lääkärini on minulle määrännyt.  1  2 3  4  5 
  
Minulle ei ole mitään haittaa kohonneesta veren- 
paineesta.     1  2 3  4  5 
 
Minun on vaikea hyväksyä sitä tosiasiaa, että  
minulla on hoitoa vaativa verenpaine.  1  2 3  4  5 
 
En halua, että minut leimataan verenpainepotilaaksi.  1  2 3  4  5 
 
Terveyskeskuksesta on kehotettu minua käymään 
useammin verenpaineen mittauksessa.  1  2 3  4  5 
 
Apteekissa on kiinnitetty huomiota siihen, etten  
käytä verenpainelääkkeitä täysin ohjeiden mukaisesti.  1  2 3  4  5 
 
 
 
 
 
 
 
 
     Täysin Jokseenkin  Jokseenkin Täysin  Ei 
samaa samaa eri  eri  koske 
mieltä  mieltä mieltä mieltä          minua 
 
En ole saanut lääkäriltä riittävästi tietoa verenpaine- 
lääkkeiden haittavaikutuksista.   1 2 3  4  5 
 
En rasita itseäni ajattelemalla aina vain verenpainettani.  1 2 3  4  5 
 
Olen jättänyt viime aikoina verenpainelääkkeeni 
ottamatta eikä siihen ole kiinnitetty terveyskeskuk- 
sessa sen enempää huomiota.   1 2 3  4  5  
 
Verenpaineeni hoitoa haittaa se, että terveyden- 
hoitaja vaihtuu niin usein.    1 2 3  4  5  
 
Lääkärini hoitaa verenpainettani vain omalla tavallaan 
eikä kuuntele minua.    1 2 3  4  5 
 
En kiinnitä paljoa huomiota kohonneeseen veren- 
paineeseeni, onhan sitä monilla muillakin.  1 2 3  4  5  
 
En usko, että lihavuudella on merkitystä veren- 
paineeseeni.    1 2 3  4  5  
 
En halua elinikäistä verenpainelääkitystä.  1 2 3  4  5 
 
Verenpaineeni hoito on vaikeutunut, koska Kelan  
verenpainelääkkeiden korvattavuusprosentti on  
aina vain pienentynyt.    1 2 3  4  5  
 
En jaksa nähdä vaivaa kohonneen verenpaineeni  
vuoksi.     1 2 3  4  5 
 
Lääkärillä on aina aikaa minulle verenpainettani 
koskevissa asioissa.    1 2 3  4  5 
 
Verenpaineen mittaaminen hoitajan suorittamana 
jännittää minua.    1 2 3  4  5 
 
Puolisoni ei usko verenpaineeni hoidon hyödyllisyyteen.  1 2 3  4  5 
 
En saa riittävästi tukea lääkäriltä verenpaineeni 
hoidossa.     1 2 3  4  5 
 
Terveydenhoitaja ’’tuputtaa’’ liikaa terveysneuvontaa.  1 2 3  4  5 
 
En saa riittävästi tukea hoitajilta verenpaineeni hoidossa.  1 2 3  4  5 
 
En ole havainnut verenpainelääkkeitteni heikentävän  
sukupuolista kyvykkyyttäni/halukkuuttani.  1 2 3  4  5 
 
Verikokeessa käynti on epämiellyttävää.  1 2 3  4  5 
 
Verenpaineen mittaaminen lääkärin suorittamana 
jännittää minua.    1 2 3  4  5 
 
 
 
 
 
Täysin Jokseenkin  Jokseenkin Täysin  Ei 
samaa samaa eri  eri  koske 
mieltä  mieltä mieltä mieltä  minua 
 
Olen yrittänyt säästää myös vähentämällä  
verenpainelääkkeiden käyttöä.   1 2 3  4  5 
 
En viitsi liikkua tarpeeksi laihtuakseni.  1 2 3  4  5 
 
Minulla ei ole varaa terveelliseen ruokavalioon.  1 2 3  4  5  
 
Pelkään, että pitkäaikainen verenpainelääkkeiden  
käyttö saattaa aiheuttaa elimistölleni haitallisia  
vaikutuksia ajan mittaan.    1 2 3  4  5 
  
En kanna huolta verenpaineestani, koska se on  
samalla tasolla kuin tuttavillanikin.   1 2 3  4  5 
 
En usko, että verenpainettani saadaan hallintaan.  1 2 3  4  5 
 
Terveyskeskuksessa on liian vähän verenpaineen 
mittausaikoja.    1 2 3  4  5 
 
Terveyskeskuksessa on kiinnitetty huomiota veren- 
painelääkkeitteni käytön epäsäännöllisyyteen.  1 2 3  4  5 
 
Minun on vaikea saada kyytiä terveyskeskukseen.  1 2 3  4  5 
 
Koen verenpaineen mittaamisen epämiellyttävänä.  1 2 3  4  5 
 
Lääkärit eivät osaa antaa tarpeeksi yksityiskohtaisia  
neuvoja, jotta laihtuisin.    1 2 3  4  5 
 
Terveydenhoitajalla käynnit eivät johda mihinkään.  1 2 3  4  5 
 
Minun on mahdotonta vaivojeni vuoksi liikkua 
tarpeeksi laihtuakseni.    1 2 3  4  5 
 
Olen kyllästynyt kokeilemaan erilaisia verenpaine- 
lääkkeitä.     1 2 3  4  5 
 
Minulla on vaikeuksia hoitaa verenpainettani 
terveyskeskusmaksujen vuoksi.   1 2 3  4  5 
 
Olen yrittänyt parhaani laihtuakseni.   1 2 3  4  5 
 
Lääkärit eivät ole kiinnostuneita minun verenpaineestani.  1 2 3  4  5 
 
Silloin tällöin voi kokeilla pärjääkö vähemmillä 
verenpainelääkkeillä.    1 2 3  4  5 
 
Tuskinpa verenpaineelleni voidaan mitään. Korkea 
verenpaine on meillä sukuvika.   1 2 3  4  5 
 
Terveydenhoitajat eivät osaa antaa tarpeeksi 
yksityiskohtaisia neuvoja, jotta laihtuisin.  1 2 3  4  5 
 
 
Ottakaa kantaa pitävätkö seuraavat asiat paikkaansa Teidän verenpaineenne hoidossa vai eivätkö pidä. 
Mikäli jokin asia ei koske Teitä valitkaa vaihtoehto 3. 
    Pitää  Ei pidä  Ei koske 
    paikkaansa       paikkaansa   minua 
 
Minun on hankala päästä haluamalleni lääkärille.   1 2  3 
 
Verenpainelääkkeitäni ei ole hyväksytty Kelan erityis- 
korvattavuuden piiriin lääkärini yrityksistä huolimatta.   1 2  3 
 
En saa hoidetuksi terveyskeskuksessa kaikkia  
verenpaineeni hoitoon liittyviä asioita yhdellä kertaa.   1 2  3 
 
Minun on vaikea valita vähäsuolaisia elintarvikkeita kaupasta.  1 2  3 
 
Työpaikallani on saatavissa vähäsuolaista ruokaa.   1 2  3 
 
Minun on vaikea välttää kotona suolaista ruokaa,  
koska muut perheenjäsenet pitävät siitä.   1 2  3 
 
Puolisoni epäilee verenpainelääkkeiden aiheuttavan 
minulle sukupuolista kyvyttömyyttä/haluttomuutta.   1 2  3 
 
Työni ei ole esteenä verenpainelääkkeiden säännölliselle  
nauttimiselle.     1 2  3 
 
Verenpainelääkkeiden säännöllinen nauttiminen on  
minulle matkojeni ja harrastusteni vuoksi hankalaa.   1 2  3 
 
Terveydenhoitajan verenpainevastaanottoajat sopivat  
minulle huonosti.     1 2  3 
 
En käy mielelläni verikokeissa, koska en jaksa olla  
pitkään ravinnotta.     1 2  3 
 
Lääkärini ei ole huolehtinut siitä, että olisin saanut verenpaine- 
lääkkeeni Kelan erityiskorvattavuuden piiriin.   1 2  3 
 
Vointini ei ole huonontunut, vaikka en ole käyttänyt 
verenpainelääkkeitä viime aikoina.    1 2  3 
 
Terveydenhoitaja on neuvonut minua riittävästi 
verenpaineeni hoidossa.     1 2  3 
 
Seuraavassa voitte esittää näkemyksiänne siitä, miten Teidän verenpaineenne hoitoa terveys-     
keskuksessa voitaisiin nykyisestä parantaa. 
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